{"SLR NAME":"Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis","References":[{"title1":"Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series","References":[{"title2":"COVID-19","References":[]},{"title2":"Critical supply shortages - The need for ventilators and personal protective equipment during the covid-19 pandemic","References":[]},{"title2":"International comparisons of intensive care: informing outcomes and improving standards","References":[{"title3":"The birth of intensive care medicine: Bjorn Ibsen's records"},{"title3":"Demystifying critical care"},{"title3":"Variation in critical care services across North American and Western Europe"},{"title3":"Clinical review: international comparisons of critical care--lessons learned"},{"title3":"Levels of Critical Care for Adult Patients"},{"title3":"A unique snapshot of intensive care resources in Australia and New Zealand"},{"title3":"Effect of nurse-to-patient ratio in the intensive care unit on pulmonary complications and resource use after hepatectomy"},{"title3":"ICU nurse-to-patient ratio is associated with complications and resource use after esophagectomy"},{"title3":"Hospital mortality in relaiton to staff workload: a 4-year study in an adult intensive-care unit"},{"title3":"Standards for nurse staffing in critical care (updated 2010)"},{"title3":"Is it time to set minimum nurse staffing levels in English hospitals?"},{"title3":"The association of registered nurse staffing levels and patient outcomes: systematic review and meta-analysis"},{"title3":"Critical care delivery in the United States: distribution of services and compliance with Leapfrog recommendations"},{"title3":"Decisions made by critical care nurses during mechanical ventilation and weaning in an Australian intensive care unit"},{"title3":"The effect of multidisciplinary care teams on intensive care unit mortality"},{"title3":"Nighttime intensivist staffing and mortality among critically ill patients"},{"title3":"Improving the comparability of cancer registry treatment data and proposals for a new national minimum dataset"},{"title3":"Standardization of terminology, definitions, and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group"},{"title3":"Standardization of terminology of virologic response in the treatment of chronic hepatitis C: panel recommendations"},{"title3":"The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination"},{"title3":"Has mortality from acute respiratory distress syndrome decreased over time?"},{"title3":"Intensive care medicine in Europe"},{"title3":"Variation in Critical Care Beds Per Capita in the United States: Implications for Pandemic and Disaster Planning"},{"title3":"Critical care and the global burden of critical illness in adults"},{"title3":"Japan's Universal and Affordable Health Care: Lessons for the United States"},{"title3":"The variability of critical care bed numbers in Europe"},{"title3":"Is there a starling curve for intensive care?"},{"title3":"Comparison of Medical Admissions to Intensive Care Units in the United States and United Kingdom"},{"title3":"Evaluation of modernisation of adult critical care services in England: time series and cost effectiveness analysis"},{"title3":"Mortality among appropriately referred patients refused admission to intensive-care units"},{"title3":"Consequences of discharges from intensive care at night"},{"title3":"Disease and disadvantage in the United States and in England"},{"title3":"Worldwide demand for critical care"},{"title3":"A comparison of intensive care unit utilization in Alberta and western Massachusetts"},{"title3":"Refusal of ICU Admission Due to a Full Unit: Impact on Mortality"},{"title3":"Survival of critically ill patients hospitalized in and out of intensive care units under paucity of intensive care unit beds"},{"title3":"Implications of ICU triage decisions on patient mortality: a cost-effectiveness analysis"},{"title3":"Intensive care unit bed availibility and outcomes for hospitalized patients with sudden clinical deterioration"},{"title3":"The implications of long-term acute care hospital transfer practices for measures of in-hospital mortality and length of stay"},{"title3":"Three-year outcomes for Medicare beneficiaries who survive intensive care"},{"title3":"Critical care medicine in the United States 2000-2005: an analysis of bed numbers, occupancy rates, payer mix, and costs"},{"title3":"The changing epidemiology of mechanical ventilation: a population-based study"},{"title3":"Regionalization of medical critical care: what can we learn from the trauma experience?"},{"title3":"A cross-cultural comparison of critical care delivery: Japan and the United States"},{"title3":"Critical Care Rationing: International Comparisons"},{"title3":"Uncharted Paths"},{"title3":"Reorganizing Adult Critical Care Delivery: the role of regionalization, telemedicine, and community outreach"},{"title3":"Reduction in critical mortality in urban mass casualty incidents: analysis of triage, surge, and resource use after the London bombings on July 7, 2005"},{"title3":"Inter-hospital transfers of acutely ill adults in Scotland"},{"title3":"Pro/con debate: Do the benefits of regionalized critical care delivery outweigh the risks of interfacility patient transport?"},{"title3":"Rationing in the intensive care unit"},{"title3":"Physicians' perceptions and attitudes regarding inappropriate admissions and resource allocation in the intensive care setting"},{"title3":"Intensive care unit admitting patterns in the veterans affairs health care system"},{"title3":"European attitudes towards ethical problems in intensive care medicine: results of an ethical questionnaire"},{"title3":"Use of intensive care services during terminal hospitalizations in England and the United States"},{"title3":"End-of-life practices in European intensive care units: the Ethicus Study"},{"title3":"A review and analysis of intensive care medicine in the least developed countries"},{"title3":"Critical care in resource-poor settings: Lessons learned and future directions"},{"title3":"Katrina, the Tsunami, and Point-of-Care Testing"},{"title3":"The epidemiology of Hajj-related critical illness: lessons for deployment of temporary critical care services"},{"title3":"Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine"},{"title3":"Mortality after fluid bolus in African children with severe infection"}]},{"title2":"Fair allocation of scarce medical resources in the time of covid-19","References":[{"title3":"Potential association between COVID-19 mortality and health-care resource availability"},{"title3":"Fair allocation of scarce medical resources in the time of Covid-19"},{"title3":"Whose life to save? Scarce resources allocation in the COVID-19 outbreak"},{"title3":"The toughest triage:allocating ventilators in a pandemic"},{"title3":"A framework for rationing ventilators and critical care beds during the COVID-19 pandemic"},{"title3":"Who gets the ventilator? Important legal rights in a pandemic"},{"title3":"Online panels in social science research: Expanding sampling methods beyond Mechanical Turk"},{"title3":"Educational Attainment in the United States: 2018"},{"title3":"Real Median Household Income in the United States [MEHOINUSA672N]"},{"title3":"The latest Gallup figures report an equal split among the three options"},{"title3":"The psychology of sunk cost"},{"title3":"Escalation and de-escalation of commitment in response to sunk costs: the role of budgeting in mental accounting"},{"title3":"Anomalies: the Endowment effect, loss aversion, and status quo bias"},{"title3":"Omission and commission in judgment and choice"},{"title3":"Availability: a heuristic for judging frequency and probability"}]},{"title2":"Characteristics and outcomes of 21 critically ill patients with covid-19 in Washington State","References":[]},{"title2":"Clinical characteristics of covid-19 in New York City","References":[{"title3":"COVID-19 Map"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Extrapulmonary manifestations of COVID-19"},{"title3":"Aki in hospitalized patients with and without COVID-19: a comparison study"},{"title3":"Aki in hospitalized patients with COVID-19"},{"title3":"Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection"},{"title3":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19"},{"title3":"Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction"},{"title3":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19"},{"title3":"Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2"},{"title3":"Thrombosis in hospitalized patients with COVID-19 in a new York City health system"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy"},{"title3":"States reporting cases of COVID-19 to CDC"},{"title3":"Defining the Epidemiology of Covid-19 - Studies Needed"},{"title3":"R: a language and environment for statistical computing. R found STAT comput Vienna, Austria; R foundation for statistical computing"},{"title3":"Epidemiology of Covid-19 in a long-term care facility in King County, Washington"},{"title3":"SARS-CoV-2 infection among travelers returning from Wuhan, China"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Estimates of the severity of coronavirus disease 2019: a model-based analysis"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Covid-19 in critically Ill patients in the seattle region - case series"},{"title3":"Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]"},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state"},{"title3":"Lactate dehydrogenase, a risk factor of severe COVID-19 patients"},{"title3":"Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis"},{"title3":"Clinical characteristics of Covid-19 in New York City"},{"title3":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application"}]},{"title2":"Covid-19 in critically ill patients in the Seattle region - case series","References":[{"title3":"Novel coronavirus : China"},{"title3":"Coronavirus COVID-19 global cases"},{"title3":"First case of 2019 novel coronavirus in the United States."},{"title3":"2019 Novel coronavirus outbreak (COVID-19)"},{"title3":"Cryptic transmission of novel coronavirus revealed by genomic epidemiology"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study."},{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response."},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State."},{"title3":"Priorities for the US health community responding to COVID-19."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Coronavirus disease 2019 (COVID-19)"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome."},{"title3":"Prone positioning in severe acute respiratory distress syndrome."},{"title3":"Bacterial coinfection in influenza: a grand rounds review."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients."},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis."},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China."},{"title3":"Care of the critically ill and injured during pandemics and disasters: groundbreaking results from the Task Force on Mass Critical Care."},{"title3":"Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement."}]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with covid-19 in the New York City area","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region","References":[]},{"title2":"Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. medRxiv. 2020.","References":[]},{"title2":"The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients","References":[]},{"title2":"NYS Department of Health. NYS Health Profiles - New York Presbyterian - Columbia Presbyterian Center 2020.","References":[]},{"title2":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","References":[{"title3":"A New Vision for the National Institutes of Health"},{"title3":"SQLGEN: a framework for rapid client-server database application development"},{"title3":"WebEAV: automatic metadata-driven generation of web interfaces to entity-attribute-value databases"},{"title3":"Model-driven development of Web applications: the Auto Web system"},{"title3":"Value of Hosted Clinical Data Environments"},{"title3":"A comparison study: paper-based versus web-based data collection and management"}]},{"title2":"Algorithm AS 217: Computation of the dip statistic to test for unimodality","References":[]},{"title2":"Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality","References":[{"title3":"Insights into the interaction between influenza virus and pneumococcus"},{"title3":"Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza"},{"title3":"Hyperactive immune cells (T cells) may be responsible for acute lung injury in influenza virus infections: a need for early immune-modulators for severe cases"},{"title3":"Increased incidence of co-infection in critically ill patients with influenza"},{"title3":"Koch RM, Kox M, de Jonge MI, van der Hoeven JG, Ferwerda G, Pickkers P: Patterns in bacterial- and viral-induced immunosuppression and secondary infections in the ICU. Shock 2016."},{"title3":"Post-infectious immune suppression: a new paradigm of severe infections"},{"title3":"Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study"},{"title3":"Influenza-Associated Aspergillosis in Critically Ill patients"},{"title3":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness"},{"title3":"Invasive aspergillosis associated with severe influenza infections"},{"title3":"Invasive fungal infections associated with prior respiratory viral infections in immunocompromised hosts"},{"title3":"Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza"},{"title3":"Reactivation of multiple viruses in patients with sepsis"},{"title3":"Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza a and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4"},{"title3":"The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. on behalf of the working group on sepsis-related problems of the european society of intensive care medicine"},{"title3":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group"},{"title3":"Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT)"},{"title3":"Innate immune evasion strategies of influenza viruses"},{"title3":"Factors associated with poor outcomes among adults hospitalized for influenza in France: a three-year prospective multicenter study"},{"title3":"Obstructive sleep apnea: implications for cardiac and vascular disease"},{"title3":"Influenza activity - United States, 2015-16 season and Composition of the 2016-17 Influenza Vaccine"},{"title3":"Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Onakpoya I, Mahtani KR, Nunan D et al: Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 2014(4):CD008965."},{"title3":"Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data"},{"title3":"The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis"},{"title3":"Influenza a virus facilitates Streptococcus pneumoniae transmission and disease"},{"title3":"Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection"},{"title3":"Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection"},{"title3":"Invasive aspergillosis complicating pandemic influenza a (H1N1) infection in severely immunocompromised patients"},{"title3":"Isolation of Aspergillus in three 2009 H1N1 influenza patients"},{"title3":"(H1N1) complicated by invasive aspergillosis in non-severely immunocompromised patients"},{"title3":"Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis"},{"title3":"Pulmonary aspergillosis in non-immunocompromised patient with acute respiratory distress syndrome during a (H1N1) infection"},{"title3":"Pandemic 2009 influenza a(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients"},{"title3":"Personalized medicine in influenza: a bridge too far or the near future?"},{"title3":"Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza a"},{"title3":"Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States"}]},{"title2":"Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain","References":[{"title3":"Pandemic (H1N1) 2009. Update 62"},{"title3":"Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico"},{"title3":"Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009"},{"title3":"Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009"},{"title3":"Situation Report. Pandemic Influenza (H1N1) 2009"},{"title3":"CDC protocol of realtime RTPCR for influenza A (H1N1). Geneva: World Health Organization, April 2009"},{"title3":"H1N1 2009 influenza virus infection during pregnancy in the USA"},{"title3":"Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults"},{"title3":"Viral pneumonia due to influenza and parainfluenza viruses and adenoviruses"},{"title3":"Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of Acute Dialysis Quality Initiative (ADQI) Group"},{"title3":"APACHE II: a severity of disease classification system"},{"title3":"The SOFA (Sepsis-Related Organ Failure Assessment) score to describe organ dysfunction/failure"},{"title3":"Vigilancia de la gripe en Espana"},{"title3":"Life-threatening respiratory failure from H1N1 influenza 09 (human swinw influenza)"},{"title3":"Influenza A virus infection and pulmonary microthormboembolism"},{"title3":"Seasonal influenza in adults and children- diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Disease society of America"},{"title3":"Update on avian influenza A (H5N1) virus infection in humans"},{"title3":"Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada"}]},{"title2":"Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness","References":[]},{"title2":"Associations between prolonged intubation and developing post-extubation dysphagia and aspiration pneumonia in non-neurologic critically ill patients","References":[{"title3":"The incidence of dysphagia following endotracheal intubation: a systematic review"},{"title3":"Dysphagia after stroke: incidence, diagnosis, and pulmonary complications"},{"title3":"Complications and consequences of endotracheal intubation and tracheotomy: a prospective study of 150 critically ill adult patients"},{"title3":"Laryngeal complications of prolonged intubation"},{"title3":"Long-term complications of artificial airways"},{"title3":"Alteration in swallowing reflex after extubation in intensive care unit patients"},{"title3":"Laryngeal injury from prolonged intubation: a prospective analysis of contributing factors"},{"title3":"Routine fiberoptic endoscopic evaluation of swallowing following prolonged intubation: implications for management"},{"title3":"Incidence and impact of dysphagia in patients receiving prolonged endotracheal intubation after cardiac surgery"},{"title3":"Postextubation fiberoptic endoscopic evaluation of swallowing after prolonged endotracheal intubation: a randomized, prospective trial"},{"title3":"Swallowing disorders post orotracheal intubation in the elderly"},{"title3":"Swallowing dysfunction after cardiac operations. Associated adverse outcomes and risk factors including intraoperative transesophageal echocardiography"},{"title3":"Risk of dysphagia after transesophageal echocardiography during cardiac operations"},{"title3":"Consequence of dysphagia in the hospitalized patient: impact on prognosis and hospital resources"},{"title3":"Post-extubation dysphagia is associated with longer hospitalization in survivors of critical illness with neurologic impairment"},{"title3":"Postextubation dysphagia is persistent and associated with poor outcomes in survivors of critical illness"},{"title3":"Duration of oral endotracheal intubation is associated with dysphagia symptoms in acute lung injury patients"},{"title3":"Aspiration pneumonia and dysphagia in the elderly"},{"title3":"ICU-acquired swallowing disorders"},{"title3":"The videofluorographic swallowing study"},{"title3":"Oropharyngeal dysphagia after cardiac operations"},{"title3":"Routine evaluation for aspiration after thoracotomy for pulmonary resection"},{"title3":"A penetration-aspiration scale"},{"title3":"Quantifying swallowing function after stroke: a functional dysphagia scale based on videofluoroscopic studies"},{"title3":"A new Simplified Acute Physiology Score (SAPS II) based on a European/ North American multicenter study"},{"title3":"APACHE II: a severity of disease classification system"},{"title3":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine"},{"title3":"Prolonged swallowing time in dysphagic Parkinsonism patients with aspiration pneumonia"},{"title3":"Clinical study of aspiration pneumonia in stroke patients"},{"title3":"Healthcare-associated pneumonia and aspiration pneumonia"},{"title3":"Critical illness polyneuropathy: clinical findings and cell culture assay of neurotoxicity assessed by a prospective study"},{"title3":"Paresis acquired in the intensive care unit: a prospective multicenter study"},{"title3":"ICU-acquired weakness and recovery from critical illness"},{"title3":"Diagnosis and treatment of postextubation dysphagia: results from a national survey"},{"title3":"Inter- and intrajudge reliability of a clinical examination of swallowing in adults"},{"title3":"Early assessments of dysphagia and aspiration risk in acute stroke patients"},{"title3":"Factors associated with swallowing assessment after oral endotracheal intubation and mechanical ventilation for acute lung injury"},{"title3":"Videofluoroscopic studies of swallowing dysfunction and the relative risk of pneumonia"},{"title3":"Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior?"},{"title3":"Prospective, randomized outcome study of endoscopy versus modified barium swallow in patients with dysphagia"}]},{"title2":"Neurologic features in severe SARS-CoV-2 Infection","References":[]},{"title2":"Virtually perfect? Telemedicine for covid-19","References":[]}]},{"title1":"COVID-19 infections and outcomes in a live registry of heart failure patients across an integrated health care system","References":[{"title2":"Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic","References":[]},{"title2":"Clinical Characteristics of Coronavirus Disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy","References":[]},{"title2":"Covid-19 in Critically Ill Patients in the Seattle Region:Case Series","References":[{"title3":"Novel coronavirus : China"},{"title3":"Coronavirus COVID-19 global cases"},{"title3":"First case of 2019 novel coronavirus in the United States."},{"title3":"2019 Novel coronavirus outbreak (COVID-19)"},{"title3":"Cryptic transmission of novel coronavirus revealed by genomic epidemiology"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study."},{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response."},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State."},{"title3":"Priorities for the US health community responding to COVID-19."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Coronavirus disease 2019 (COVID-19)"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome."},{"title3":"Prone positioning in severe acute respiratory distress syndrome."},{"title3":"Bacterial coinfection in influenza: a grand rounds review."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients."},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis."},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China."},{"title3":"Care of the critically ill and injured during pandemics and disasters: groundbreaking results from the Task Force on Mass Critical Care."},{"title3":"Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement."}]},{"title2":"Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry","References":[]},{"title2":"https://www.census.gov/quickfacts/fact/table/hartfordcityconnecticut,newhavencitycon necticut,bridgeportcityconnecticut,CT,US/INC110218","References":[]},{"title2":"COVID-19 and African Americans","References":[{"title3":"COVID-19: a review on the novel coronavirus disease evolution, transmission, detection, control and prevention"},{"title3":"The third coronavirus epidemic in the third millennium: what's next?"},{"title3":"An interactive web-based dashboard to track COVID-19 in real time"},{"title3":"Long-term complications of COVID-19"},{"title3":"Association between COVID-19 and myocarditis using hospital-based administrative data - United States, March 2020-January 2021"},{"title3":"Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management"},{"title3":"Variants in SARS-CoV-2 associated with mild or severe outcome"},{"title3":"Mortality among US patients hospitalized with SARS-CoV-2 infection in 2020"},{"title3":"Features, Evaluation, and Treatment of Coronavirus (COVID-19)"},{"title3":"Cardiovascular disease and COVID-19"},{"title3":"Myocarditis after COVID-19 vaccination in a large health care organization"}]},{"title2":"Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19","References":[]},{"title2":"Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"WHO Coronavirus (COVID-19) Dashboard"},{"title3":"Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: A systemic review and meta-analysis"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Coronavirus disease 2019 case surveillance - United States"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel Coronavirus diseases (COVID-19) - China"},{"title3":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC"},{"title3":"Hypothesis: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19"},{"title3":"Extrapulmonary manifestations of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target"},{"title3":"Preventing a COVID-19 pandemic"},{"title3":"SARS-CoV2: Should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?"},{"title3":"Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and risk of COVID-19"},{"title3":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China"},{"title3":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)"},{"title3":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: A prospective, randomised, open-label trial"},{"title3":"Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): A prospective, parallel group, randomised, controlled, open-label trial"},{"title3":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: A randomized clinical trial"},{"title3":"Effects of renin-angiotensin-aldosterone inhibitors on early outcomes of hypertensive COVID-19 patients: A randomized triple-blind clinical trial"},{"title3":"The use of propensity score methods with survival or time-to-event outcomes: Reporting measures of effect similar to those used in randomized experiments"},{"title3":"Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes"},{"title3":"Comparison of evidence of treatment effects in randomized and nonrandomized studies"},{"title3":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews"},{"title3":"The cochrane collaboration's tool for assessing risk of bias in randomised trials"},{"title3":"Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; 2021. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp."},{"title3":"Measuring inconsistency in meta-analyses"},{"title3":"Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis"},{"title3":"Effects of recent use of renin-angiotensin system inhibitors on mortality of patients with coronavirus disease 2019"},{"title3":"Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: A retrospective cohort study"},{"title3":"Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans"},{"title3":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: A retrospective observational study"},{"title3":"Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension"},{"title3":"The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension"},{"title3":"Clinical features of COVID-19 in patients with essential hypertension and the impacts of renin-angiotensin-aldosterone system inhibitors on the prognosis of COVID-19 patients"},{"title3":"Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea"},{"title3":"A retrospective study from 2 centers in China on the effects of continued use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with hypertension and COVID-19"},{"title3":"Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: A retrospective observational study"},{"title3":"Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis"},{"title3":"Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: A systematic review and meta-analysis"},{"title3":"Associations between the use of renin-angiotensin system inhibitors and the risks of severe COVID-19 and mortality in COVID-19 patients with hypertension: A meta-analysis of observational studies"},{"title3":"Mortality and severity in COVID-19 patients on ACEIs and ARBs - A systematic review, meta-analysis, and meta-regression analysis"},{"title3":"Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults: A living systematic review"},{"title3":"Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF program"}]},{"title2":"Fair Allocation of Scarce Medical Resources in the Time of Covid-19","References":[{"title3":"Potential association between COVID-19 mortality and health-care resource availability"},{"title3":"Fair allocation of scarce medical resources in the time of Covid-19"},{"title3":"Whose life to save? Scarce resources allocation in the COVID-19 outbreak"},{"title3":"The toughest triage:allocating ventilators in a pandemic"},{"title3":"A framework for rationing ventilators and critical care beds during the COVID-19 pandemic"},{"title3":"Who gets the ventilator? Important legal rights in a pandemic"},{"title3":"Online panels in social science research: Expanding sampling methods beyond Mechanical Turk"},{"title3":"Educational Attainment in the United States: 2018"},{"title3":"Real Median Household Income in the United States [MEHOINUSA672N]"},{"title3":"The latest Gallup figures report an equal split among the three options"},{"title3":"The psychology of sunk cost"},{"title3":"Escalation and de-escalation of commitment in response to sunk costs: the role of budgeting in mental accounting"},{"title3":"Anomalies: the Endowment effect, loss aversion, and status quo bias"},{"title3":"Omission and commission in judgment and choice"},{"title3":"Availability: a heuristic for judging frequency and probability"}]},{"title2":"Palliative care in congestive heart failure","References":[{"title3":"Heart disease and stroke statistics - 2015 update: A report from the American Heart Association."},{"title3":"Long-term trends in the incidence of and survival with heart failure."},{"title3":"Trends in heart failure incidence and survival in a community-based population."},{"title3":"Repeated hospitalizations predict mortality in the community population with heart failure."},{"title3":"&quot;Not the 'grim reaper service'&quot;: An assessment of provider knowledge, attitudes, and perceptions regarding palliative care referral barriers in heart failure."},{"title3":"The need for palliative care in the management of heart failure."},{"title3":"Symptom burden, depression, and spiritual well-being: A comparison of heart failure and advanced cancer patients."},{"title3":"A comparison between end-of-life home care clients with cancer and heart failure in Ontario."},{"title3":"Removing the boundaries: Palliative care for patients with heart failure."},{"title3":"Failing the failing heart: A review of palliative care in heart failure."},{"title3":"Patterns of functional decline at the end of life."},{"title3":"2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines."},{"title3":"Palliative care and cardiovascular disease and stroke: A policy statement from the American Heart Association/American Stroke Association."},{"title3":"Effects of person-centred and integrated chronic heart failure and palliative home care. PREFER: A randomized controlled study."},{"title3":"Inpatient palliative care for patients with acute heart failure: Outcomes from a randomized trial."},{"title3":"Effects of a transitional palliative care model on patients with end-stage heart failure: A randomised controlled trial."},{"title3":"Palliative care in heart failure: The PAL-HF randomized, controlled clinical trial."},{"title3":"End-of-life care in patients with heart failure."},{"title3":"The use of digoxin in patients with worsening chronic heart failure: Reconsidering an old drug to reduce hospital admissions."},{"title3":"Illness trajectories and palliative care."},{"title3":"Physician attitudes toward end-stage heart failure: A national survey."},{"title3":"Palliative care for people with chronic heart failure: When is it time?"},{"title3":"Palliative care in congestive heart failure."},{"title3":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction."},{"title3":"Deactivation of pacemakers and implantable cardioverter-defibrillators."},{"title3":"Higher New York heart association classes and increased mortality and hospitalization in heart failure patients with preserved left ventricular function."},{"title3":"Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure."},{"title3":"Natriuretic peptides, ejection fraction, and prognosis: Parsing the phenotypes of heart failure."},{"title3":"The Seattle Heart Failure Model: prediction of survival in heart failure."},{"title3":"Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation."},{"title3":"Prediction of mode of death in heart failure: The Seattle heart failure model."},{"title3":"End-of-life heart failure care in the United States."},{"title3":"Palliative care and hospice in advanced heart failure."},{"title3":"Who needs a heart transplant?"},{"title3":"Palliative care in heart failure: A position statement from the palliative care workshop of the heart failure association of the European Society of Cardiology."},{"title3":"&quot;Sometimes we can't fix things&quot;: A qualitative study of health care professionals' perceptions of end of life care for patients with heart failure."},{"title3":"Health care professionals' attitudes regarding palliative care for patients with chronic heart failure: An interview study."},{"title3":"Discharge hospice referral and lower 30-day all-cause readmission in medicare beneficiaries hospitalized for heart failure."},{"title3":"Hospice enrollment in patients with advanced heart failure decreases acute medical service utilization."},{"title3":"Palliative care for heart failure: Time to move beyond treating and curing to improving the end of life."},{"title3":"Understanding palliative care on the heart failure care team: an innovative research methodology."},{"title3":"Hospice, opiates, and acute care service use among the elderly before death from heart failure or cancer."},{"title3":"Integrating the complementary skills of palliative care and cardiology to develop care models supporting the needs of those with advanced heart failure."},{"title3":"Doctors' perceptions of palliative care for heart failure: Focus group study."},{"title3":"A survey of clinician attitudes and self-reported practices regarding end-of-life care in heart failure."},{"title3":"Heart failure and palliative care: implications in practice."},{"title3":"A comparative study of the palliative care needs of heart failure and cancer patients."},{"title3":"A model of palliative care for heart failure."},{"title3":"Managing palliative care for adults with advanced heart failure."},{"title3":"Integrating palliative care into heart failure care."},{"title3":"Top 10 things palliative care clinicians wished everyone knew about palliative care."},{"title3":"Preferences of patients with heart failure for prognosis communication."},{"title3":"Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment."},{"title3":"Advance directives in community patients with heart failure."},{"title3":"Advance directives among hospitalized patients with heart failure."},{"title3":"Living with advanced heart failure: A prospective, community based study of patients and their carers."},{"title3":"Advance care planning in the primary care setting: a comparison of attending staff and resident barriers."},{"title3":"Meeting the communication and information needs of chronic heart failure patients."},{"title3":"End-of-life care conversations with heart failure patients: A systematic literature review and narrative synthesis."},{"title3":"Living with and dying from advanced heart failure: Understanding the needs of older patients at the end of life."},{"title3":"Symptom distress in advanced chronic organ failure: Disagreement among patients and family caregivers."},{"title3":"Caregivers' perceptions of illness severity and end of life service utilization in advanced heart failure."},{"title3":"Knowledge and communication difficulties for patients with chronic heart failure: Qualitative study."},{"title3":"Prognosis communication in serious illness: Perceptions of older patients, caregivers, and clinicians."},{"title3":"Integrated, collaborative palliative care in heart failure: The St. George heart failure service experience 1999-2002."},{"title3":"An official American Thoracic Society clinical policy statement: Palliative care for patients with respiratory diseases and critical illnesses."}]}]},{"title1":"Characteristics and Clinical Outcomes of Adult Patients Hospitalized with COVID-19  Georgia, March 2020","References":[{"title2":"First case of 2019 novel coronavirus in the United States.","References":[{"title3":"Pneumonia of unknown cause : China."},{"title3":"Novel coronavirus : China."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"2019 Novel coronavirus, Wuhan, China: 2019-nCoV situation summary."},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam."},{"title3":"Wuhan coronavirus (2019-nCoV) global cases"},{"title3":"Interim guidance for healthcare professionals: criteria to guide evaluation of patients under investigation (PUI) for 2019-nCoV."},{"title3":"Infection control. 2019 Novel coronavirus, Wuhan, China."},{"title3":"A randomized, controlled trial of ebola virus disease therapeutics."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)."},{"title3":"Real-time RT-PCR panel for detection 2019-novel coronavirus."},{"title3":"2019-novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes."},{"title3":"Information for laboratories. 2019 novel coronavirus, Wuhan, China."},{"title3":"GenBank overview"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Novel coronavirus outbreak 2020"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."}]},{"title2":"Research electronic data capture (REDCap):a metadata-driven methodology and workflow process for providing translational research informatics support.","References":[{"title3":"A New Vision for the National Institutes of Health"},{"title3":"SQLGEN: a framework for rapid client-server database application development"},{"title3":"WebEAV: automatic metadata-driven generation of web interfaces to entity-attribute-value databases"},{"title3":"Model-driven development of Web applications: the Auto Web system"},{"title3":"Value of Hosted Clinical Data Environments"},{"title3":"A comparison study: paper-based versus web-based data collection and management"}]},{"title2":"Covid-19 in critically ill patients in the Seattle region:case series.","References":[{"title3":"Novel coronavirus : China"},{"title3":"Coronavirus COVID-19 global cases"},{"title3":"First case of 2019 novel coronavirus in the United States."},{"title3":"2019 Novel coronavirus outbreak (COVID-19)"},{"title3":"Cryptic transmission of novel coronavirus revealed by genomic epidemiology"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study."},{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response."},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State."},{"title3":"Priorities for the US health community responding to COVID-19."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Coronavirus disease 2019 (COVID-19)"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome."},{"title3":"Prone positioning in severe acute respiratory distress syndrome."},{"title3":"Bacterial coinfection in influenza: a grand rounds review."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients."},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis."},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China."},{"title3":"Care of the critically ill and injured during pandemics and disasters: groundbreaking results from the Task Force on Mass Critical Care."},{"title3":"Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement."}]},{"title2":"Community mitigation guidelines to prevent pandemic influenza:United States, 2017.","References":[{"title3":"Selecting nonpharmaceutical strategies to minimize influenza spread: the 2009 influenza A (H1N1) pandemic and beyond."},{"title3":"Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010)."},{"title3":"Epidemiology of 2009 pandemic influenza A (H1N1) in the United States."},{"title3":"Detection of extensive cross-neutralization between pandemic and seasonal A/H1N1 influenza viruses using a pseudotype neutralization assay."},{"title3":"Novel virus influenza A (H1N1sw) in South-Eastern France, April-August 2009."},{"title3":"Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009."},{"title3":"H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes."},{"title3":"Neonatal outcomes after antenatal influenza immunization during the 2009 H1N1 influenza pandemic: impact on preterm birth, birth weight, and small for gestational age birth."},{"title3":"Update: novel influenza A (H1N1) virus infection:Mexico, March-May, 2009."},{"title3":"Swine influenza A (H1N1) infection in two children:Southern California, March-April 2009."},{"title3":"ILI-related school dismissal monitoring system: an overview and assessment."},{"title3":"Effects of hand hygiene campaigns on incidence of laboratory-confirmed influenza and absenteeism in schoolchildren, Cairo, Egypt."},{"title3":"School opening dates predict pandemic influenza A(H1N1) outbreaks in the United States."},{"title3":"Effectiveness of a school district closure for pandemic influenza A (H1N1) on acute respiratory illnesses in the community: a natural experiment."},{"title3":"Effects of school closure on incidence of pandemic influenza in Alberta, Canada."},{"title3":"Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico."},{"title3":"Multiple outbreaks for the same pandemic: local transportation and social distancing explain the different &quot;waves&quot; of A-H1N1pdm cases observed in Mexico during 2009."},{"title3":"Response to 2009 pandemic influenza A H1N1 among public schools of Georgia, United States:fall 2009."},{"title3":"Targeted antiviral prophylaxis with oseltamivir in a summer camp setting."},{"title3":"Outbreaks of pandemic (H1N1) 2009 and seasonal influenza A (H3N2) on cruise ship."},{"title3":"Use of antiviral drugs to reduce household transmission of pandemic (H1N1) 2009, United Kingdom."},{"title3":". Harvard Opinion Research Program [Internet]. Public response to H1N1. Boston, MA: Harvard TH Chan School of Public Health. https://www.hsph.harvard.edu/horp/project-on-the-public-response-to-h1n1"},{"title3":"Parental attitudes and experiences during school dismissals related to 2009 influenza A (H1N1):United States, 2009."},{"title3":"Implementation of non-pharmaceutical interventions by New York City public schools to prevent 2009 influenza A."},{"title3":"Variability in school closure decisions in response to 2009 H1N1: a qualitative systems improvement analysis."},{"title3":"The epidemiology and surveillance response to pandemic influenza A (H1N1) among local health departments in the San Francisco Bay Area."},{"title3":"School closure as an influenza mitigation strategy: how variations in legal authority and plan criteria can alter the impact."},{"title3":"Pandemic influenza as 21st century urban public health crisis."},{"title3":"Exploring communication, trust in government, and vaccination intention later in the 2009 H1N1 pandemic: results of a national survey."},{"title3":"Re-emergence of fatal human influenza A subtype H5N1 disease."},{"title3":"Household effects of school closure during pandemic (H1N1) 2009, Pennsylvania, USA."},{"title3":"Closing schools in response to the 2009 pandemic influenza A H1N1 virus in New York City: economic impact on households."},{"title3":"Social and economic impact of school closure resulting from pandemic influenza A/H1N1."},{"title3":"Contact behaviour of children and parental employment behaviour during school closures against the pandemic influenza A (H1N1-2009) in Japan."},{"title3":"Hand hygiene instruction decreases illness-related absenteeism in elementary schools: a prospective cohort study."},{"title3":"Updated preparedness and response framework for influenza pandemics."},{"title3":"Novel framework for assessing epidemiologic effects of influenza epidemics and pandemics."},{"title3":"Non-pharmaceutical interventions for pandemic influenza, national and community measures."},{"title3":"Public health. Next flu pandemic: what to do until the vaccine arrives?"},{"title3":"Public health interventions and epidemic intensity during the 1918 influenza pandemic."},{"title3":"Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic."},{"title3":"Reducing the impact of the next influenza pandemic using household-based public health interventions."},{"title3":"Strategies for mitigating an influenza pandemic."},{"title3":"Modeling targeted layered containment of an influenza pandemic in the United States."},{"title3":"Infection control and pandemic influenza."},{"title3":"Transmission of influenza A in human beings."},{"title3":"Nosocomial influenza infection as a cause of intercurrent fevers in infants."},{"title3":"The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts."},{"title3":"Survival of influenza viruses on environmental surfaces."},{"title3":"Survival of influenza virus on human fingers."},{"title3":"Estimating influenza latency and infectious period durations using viral excretion data."},{"title3":"The annual impact of seasonal influenza in the U.S.: measuring disease burden and costs."},{"title3":"Viral shedding in children with influenza virus infections treated with neuraminidase inhibitors."},{"title3":"Viral shedding patterns of children with influenza B infection."},{"title3":"Illness among schoolchildren during influenza season: effect on school absenteeism, parental absenteeism from work, and secondary illness in families."},{"title3":"Interpandemic influenza in the Houston area, 1974-76."},{"title3":"Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness."},{"title3":"Social contact networks and mixing among students in K-12 schools in Pittsburgh, PA."},{"title3":"Estimates of social contact in a middle school based on self-report and wireless sensor data."},{"title3":"Estimating the impact of school closure on social mixing behaviour and the transmission of close contact infections in eight European countries."},{"title3":"The impact of illness and the impact of school closure on social contact patterns."},{"title3":"The effectiveness of vaccination against influenza in healthy, working adults."},{"title3":"Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren."},{"title3":"The Japanese experience with vaccinating schoolchildren against influenza."},{"title3":"Acute respiratory illnesses in university (1962-1966), military and industrial (1962-1963) populations."},{"title3":"Outbreak of influenza A/USSR/77 at Marquette University."},{"title3":"Infectious disease in a total institution: a study of the influenza epidemic of 1978 on a college campus."},{"title3":"Influenza A/USSR/77 (H1N1) on a university campus."},{"title3":"Colds and influenza-like illnesses in university students: impact on health, academic and work performance, and health care use."},{"title3":"Burden of upper respiratory illnesses among college and university students: 2002-2003 and 2003-2004 cohorts."},{"title3":"Notes from the field: outbreak of 2009 pandemic influenza A (H1N1) virus at a large public university in Delaware, April-May 2009."},{"title3":"Transmission characteristics of different students during a school outbreak of (H1N1) pdm09 influenza in China, 2009."},{"title3":"Community-wide surveillance of influenza after outbreaks due to H3N2 (A/Victoria/75 and A/Texas/77) and H1N1 (A/USSR/77) influenza viruses, Mercer County, New Jersey, 1978."},{"title3":"Influenza vaccination among college and university students: impact on influenzalike illness, health care use, and impaired school performance."},{"title3":"Why is school closed today? Unplanned K-12 school closures in the United States, 2011-2013."},{"title3":"The effect of reactive school closure on community influenza-like illness counts in the state of Michigan during the 2009 H1N1 pandemic."},{"title3":"Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations."},{"title3":"Influenza a common viral infection among Hajj pilgrims: time for routine surveillance and vaccination."},{"title3":"Global perspectives for prevention of infectious diseases associated with mass gatherings."},{"title3":"Community transmission of influenza A (H1N1)v virus at a rock festival in Belgium, 2-5 July 2009."},{"title3":"Pandemic influenza: mass gatherings and mass infection."},{"title3":"Mass gatherings and respiratory disease outbreaks in the United States:should we be worried? Results from a systematic literature review and analysis of the National Outbreak Reporting System."},{"title3":"Influenza outbreaks during World Youth Day 2008 mass gathering."},{"title3":"The impact of mass gatherings and holiday traveling on the course of an influenza pandemic: a computational model."},{"title3":"Circulation of respiratory viruses among pilgrims during the 2012 Hajj pilgrimage."},{"title3":"Mass gathering and globalization of respiratory pathogens during the 2013 Hajj."},{"title3":"Exposure to influenza virus aerosols during routine patient care."},{"title3":"Inactivation of influenza A viruses in the environment and modes of transmission: a critical review."},{"title3":"[Asian influenza surveillance]"},{"title3":"The influenza A (H1N1-2009) experience at the inaugural Asian Youth Games Singapore 2009: mass gathering during a developing pandemic."},{"title3":"Simulation suggests that rapid activation of social distancing can arrest epidemic development due to a novel strain of influenza."},{"title3":"Precautionary behavior in response to perceived threat of pandemic influenza."},{"title3":"Mitigating pandemic influenza: the ethics of implementing a school closure policy."}]},{"title2":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019:COVID-NET, 14 states, March 1-30, 2020.","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"The US Influenza Hospitalization Surveillance Network."},{"title3":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 : United States, February 12-March 28, 2020."},{"title3":"Estimating influenza disease burden from population-based surveillance data in the United States."}]}]},{"title1":"Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study","References":[{"title2":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak"},{"title3":"The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give to travellers? : Interim recommendations January 2020, from the Latin-American Society for Travel Medicine (SLAMVI)"},{"title3":"A novel coronavirus emerging in China:key questions for impact assessment"},{"title3":"The fight against the 2019-nCoV outbreak: an arduous march has just begun"},{"title3":"Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients"},{"title3":"Recommendations and guidelines for the treatment of pneumonia in Taiwan"},{"title3":"Community-acquired adenoviral and pneumococcal pneumonia complicated by pulmonary aspergillosis in an immunocompetent adult"},{"title3":"Severe community-acquired pneumonia due to Pseudomonas aeruginosa coinfection in an influenza A(H1N1)pdm09 patient"},{"title3":"Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units"},{"title3":"Molecular epidemiology and clinical features of rhinovirus infections among hospitalized patients in a medical center in Taiwan"},{"title3":"Molecular epidemiology and clinical features of adenovirus infection in Taiwanese children, 2014"},{"title3":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travelers from Wuhan, China, 20-28 January 2020"},{"title3":"Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus"},{"title3":"Epidemiological characteristics of 2019 novel coronavirus: an interim review"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist"},{"title3":"Emerging coronavirus 2019-nCoV pneumonia"},{"title3":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV"},{"title3":"Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century"},{"title3":"Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China"},{"title3":"The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures"},{"title3":"World Health Organization (WHO). Novel coronavirus (2019-nCoV). Situation report. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200207-sitrep-18-ncov.pdf?sfvrsn=fa644293_2[accessed 9 February 2020]."},{"title3":"Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak:United States, December 31, 2019-February 4, 2020"},{"title3":"Effects of air temperature and relative humidity on coronavirus survival on surfaces"},{"title3":"Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents"},{"title3":"Clinical characteristics of 2019 novel coronavirus infection in China"},{"title3":"Coronavirus infections and immune responses"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020","References":[{"title3":"European Centre for Disease Prevention and Control (ECDC). Novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK - sixth update, 12 March 2020. ECDC: Stockholm; 2020. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/RRA-sixth-update-Outbreak-of-novel-coronavirus-disease-2019-COVID-19.pdf"},{"title3":"First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020."},{"title3":"WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. World Health Organization: Geneva; 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020"},{"title3":"First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020."},{"title3":"World Health Organization (WHO). Coronavirus disease (COVID-19) technical guidance: Surveillance and case definitions. Geneva: WHO; 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/surveillance-and-case-definitions"},{"title3":"European Centre for Disease Prevention and Control. Situation update as of 15 March 2020 08:00. Distribution of COVID-19 cases worldwide, as of 15 March 2020. [Accessed 15 Mar 2020]. Available from: https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases"},{"title3":"European Society of Intensive Care Medicine. Shared experience &amp; guidance from our colleagues in Northern Italy. 5 March 2020. [Accessed 9 March 2020]. Available from: https://www.esicm.org/covid-19-update-from-our-colleagues-in-northern-italy/"},{"title3":"Baldi C. Allarme dei sanitari Lombardi: &quot;Le nostre strutture sottoposte aa pressione superior a ogni possibilita di riposte&quot; [Alarm from healthcare professionals in Lombardy: &quot;Our structures are under a pressure which is superior to any possibility of response&quot;]. La Stampa, 8 March 2020. Italian. [Accessed 9 Mar 2020]. Available from: https://www.lastampa.it/topnews/primo-piano/2020/03/08/news/allarme-dei-sanitari-lombardi-le-nostre-strutture-sottoposte-a-pressione-superiore-a-ogni-possibilita-di-risposta-1.38566390"},{"title3":"Bocci M. Coronavirus, l'anestesita Petrini: &quot;Oggi la scelta di chi curare richiede regole certe&quot; [Coronavirus, the anaestesiologist Petrini: &quot;Today the choice of whom to cure requires clear recommendations&quot;]. La Repubblica, 8 March 2020. Italian. [Accessed 9 March 2020]. Available from: https://www.repubblica.it/cronaca/2020/03/08/news/petrini_oggi_la_scelta_di_chi_curare_richiede_regole_certe_-250594687/"},{"title3":"Chi. Bal. Una tenda davanti all'ingresso. Cremona, ospedale al collasso: &quot;Non c'e spazio per i pazienti&quot; [A tent in front of the entrance. Cremona, hospital facing collapse: &quot;We do not have room for the patients&quot;]. La Stampa, 8 March 2020. Italian. [Accessed 9 Mar 2020]. Available from: https://www.lastampa.it/cronaca/2020/02/28/news/una-tenda-davanti-all-ingresso-cremona-ospedale-al-collasso-non-c-e-spazio-per-i-pazienti-1.38525490"},{"title3":"Imarisio M. Coronavirus, il medico di Bergamo: &lt;&lt;Negli ospedali siamocome in guerra. A tutti dico: state a casa&gt;&gt; [Coronavirus, a doctor from Bergamo: &lt;&lt;In the hospitals we are like in a war scene. I am telling everyone: stay home&gt;&gt;]. Corriere della Serra, 8 March 2020. Italian. [Accessed 9 Mar 2020]. Available from: https://www.corriere.it/cronache/20_marzo_09/coronavirus-scegliamo-chi-curare-chi-no-come-ogni-guerra-196f7d34-617d-11ea-8f33-90c941af0f23_preview.shtml?reason=unauthenticated&amp;cat=1&amp;cid=sTfRVocj&amp;pids=FR&amp;credits=1&amp;origin=https%3A%2F%2Fwww.corriere.it%2Fcronache%2F20_marzo_09%2Fcoronavirus-scegliamo-chi-curare-chi-no-come-ogni-guerra-196f7d34-617d-11ea-8f33-90c941af0f23.shtml"},{"title3":"Dans mon hopital, il y a environ un ou deux deces par jour&gt;&gt;. [Coronavirus in Lombardy: &quot;In my hospital there are around one to two deaths per day&quot;]"},{"title3":"Horowitz J. Italy's Health Care System Groans Under Coronavirus : a Warning to the World. The New York Times, 12 March 2020. [Accessed 15 March 2020]. Available from: https://www.nytimes.com/2020/03/12/world/europe/12italy-coronavirus-health-care.html"},{"title3":"The variability of critical care bed numbers in Europe."}]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Defining the epidemiology of Covid-19:studies needed","References":[]},{"title2":"The representativeness of sentinel practice networks","References":[]},{"title2":"Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile","References":[{"title3":"Representativeness of patients and providers in the Canadian Primary Care Sentinel Surveillance Network: a cross-sectional study"},{"title3":"Weekly Returns Service of the Royal College of General Practitioners"},{"title3":"Health monitoring in sentinel practice networks: the contribution of primary care"},{"title3":"Improving disease incidence estimates in primary care surveillance systems"},{"title3":"The use of routinely collected computer data for research in primary care: opportunities and challenges"},{"title3":"Approaches to the denominator in practice-based epidemiology: a critical overview"},{"title3":"Population estimates of persons presenting to general practitioners with influenza-like illness, 1987-96: a study of the demography of influenza-like illness in sentinel practice networks in England and Wales, and in The Netherlands"},{"title3":"Black/White comparisons of deaths preventable by medical intervention: United States and the District of Columbia 1980-1986"},{"title3":"Disparities in testing for renal function in UK primary care: cross-sectional study"},{"title3":"Patient race and ethnicity in primary care management of child behavior problems: a report from PROS and ASPN. Pediatric Research in Office Settings. Ambulatory Sentinel Practice Network"},{"title3":"Geographic representativeness for sentinel influenza surveillance: implications for routine surveillance and pandemic preparedness"},{"title3":"Practice patterns of family physicians in practice-based research networks: a report from ASPN. Ambulatory Sentinel Pratice Network"},{"title3":"Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results"},{"title3":"Methods to identify the target population: implications for prescribing quality indicators"},{"title3":"Prevalence and epidemiology of diabetes in Canadian primary care practices: a report from the Canadian Primary Care Sentinel Surveillance Network"},{"title3":"The representativeness of sentinel practice networks"},{"title3":"Ethnicity recording in general practice computer systems"},{"title3":"Postcodes (Enumeration) to output areas to lower layer SOA to middle layer SOA to local authority districts E+W lookup"},{"title3":"The English Indices of Deprivation 2015"},{"title3":"Clinical commissioning groups (Eng) Jul 2015 Boundaries"},{"title3":"maptools: Tools for reading and handling spatial objects. R package version 0.8-27"},{"title3":"Quality and Outcomes Framework (QOF):2014-15"},{"title3":"Routinely-collected general practice data are complex, but with systematic processing can be used for quality improvement and research"},{"title3":"Prescription Cost Analysis Data: Prescribing and Primary Care Services"},{"title3":"Seasonal influenza vaccine uptake amongst GP patients in England: Final monthly data for 1 September 2014 to 31 January 2015"},{"title3":"Multiple significance tests: the Bonferroni method"},{"title3":"The Bonferonni and Sidak corrections for multiple comparisons"},{"title3":"Recorded quality of primary care for patients with diabetes in England before and after the introduction of a financial incentive scheme: a longitudinal observational study"},{"title3":"QRESEARCH: a new general practice database for research"},{"title3":"Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research"},{"title3":"Representativeness and optimal use of body mass index (BMI) in the UK Clinical Practice Research Datalink (CPRD)"},{"title3":"A review of uses of health care utilization databases for epidemiologic research on therapeutics"},{"title3":"How representative is the population covered by the RCGP spotter practice scheme? Using Geographical Information Systems to assess"},{"title3":"Use of a large general practice syndromic surveillance system to monitor the progress of the influenza A (H1N1) pandemic 2009 in the UK"},{"title3":"The CPRD and the RCGP: building on research success by enhancing benefits for patients and practices"},{"title3":"Rethinking the appraisal and approval of drugs for type 2 diabetes"},{"title3":"Basing approval of drugs for type 2 diabetes on real world outcomes"},{"title3":"Beyond the Randomized Clinical Trial: The Role of Effectiveness Studies in Evaluating Cardiovascular Therapies"}]},{"title2":"RCGP Research and Surveillance Centre: 50 years' surveillance of influenza, infections, and respiratory conditions","References":[]},{"title2":"Weekly returns service of the Royal College of General Practitioners","References":[]},{"title2":"End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19","References":[]},{"title2":"Uptake and effectiveness of influenza vaccine in those aged 65 years and older in the United Kingdom, influenza seasons 2010/11 to 2016/17","References":[{"title3":"Influenza vaccine uptake in the elderly: results from a rapid assessment of the effectiveness of new government policy in England for the winters 2000/2001 and 2001/2002."},{"title3":"Influenza deaths in Leicestershire during the 1989-90 epidemic: implications for prevention."},{"title3":"Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database."},{"title3":"Public Health England (PHE). Seasonal influenza vaccine uptake in GP patients: winter season 2016 to 2017. Final data for 1 September 2016 to 31 January 2017. London: PHE; 2017. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/613452/Seasonal_influenza_vaccine_uptake_in_GP_patients_winter_season_2016_to_2017.pdf "},{"title3":"Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999-2010."},{"title3":"End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17."},{"title3":"Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence."},{"title3":"Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile."},{"title3":"Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017."},{"title3":"Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results."},{"title3":"Public Health England (PHE). Influenza: the green book, chapter 19. Influenza immunisation information including updates for public health professionals. London: PHE; 2018. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/663694/Greenbook_chapter_19_Influenza_.pdf "},{"title3":"Development of a multiplex real-time RT-PCR that allows universal detection of influenza A viruses and simultaneous typing of influenza A/H1N1/2009 virus."},{"title3":"Zambon M. Laboratory Diagnosis of Influenza. In: Nicholson K, Hay A, Webster RG, editors. Textbook of Influenza. Oxford: Blackwell Science; 1998. pp. 291-313."},{"title3":"European Centre for Disease Prevention and Control (ECDC). Technical report: Seasonal influenza vaccination in Europe, vaccination recommendations and coverage rates in the EU member states for periods 2007/08 to 2014/15. Stockholm: ECDC; 2017. Available from: https://ecdc.europa.eu/sites/portal/files/documents/influenza-vaccination-2007%E2%80%932008-to-2014%E2%80%932015.pdf "},{"title3":"Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results."},{"title3":"The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects."},{"title3":"A randomised, partially observer blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apart."},{"title3":"Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study."},{"title3":"Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies."},{"title3":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis."},{"title3":"Mid-season real-time estimates of seasonal influenza vaccine effectiveness in persons 65 years and older in register-based surveillance, Stockholm County, Sweden, and Finland, January 2017."},{"title3":"Higgins Geoff, Komadina Naomi, Leung Vivian KY, Minney-Smith Cara A, Teng Don, Tran Thomas, Stocks Nigel, Fielding James E. Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017."},{"title3":"Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses."},{"title3":"A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine."},{"title3":"Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains."},{"title3":"I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination?"},{"title3":"Predictors of influenza immunization in persons over age 65."},{"title3":"The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly."},{"title3":"Is the adjuvanted influenza vaccine more effective than the trivalent inactivated vaccine in the elderly population? Results of a case-control study."},{"title3":"Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis."},{"title3":"Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012-2013 and 2013-2014."},{"title3":"Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis."},{"title3":"Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older."},{"title3":"Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis."},{"title3":"Uptake and impact of vaccinating school age children against influenza during a season with circulation of drifted influenza A and B strains, England, 2014/15."},{"title3":"Prescribing of neuraminidase inhibitors for influenza in UK primary care since the 2009 pandemic."},{"title3":"Evaluating the case-positive, control test-negative study design for influenza vaccine effectiveness for the frailty bias."},{"title3":"Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season."},{"title3":"Evaluating the effectiveness, impact and safety of live attenuated and seasonal inactivated influenza vaccination: protocol for the Seasonal Influenza Vaccination Effectiveness II (SIVE II) study."}]},{"title2":"Ten lessons for the next influenza pandemic:an English perspective: a personal reflection based on community surveillance data","References":[]},{"title2":"Serological surveillance of influenza in an English sentinel network: pilot study protocol","References":[{"title3":"Use of serological surveys to generate key insights into the changing global landscape of infectious disease"},{"title3":"IgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 hemagglutinin in infected persons during the first wave of the 2009 pandemic in the United States"},{"title3":"Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting"},{"title3":"Seroprevalence of influenza A(H1N1)pdm09 virus antibody, England, 2010 and 2011"},{"title3":"Pandemic preparedness and response--lessons from the H1N1 influenza of 2009"},{"title3":"RCGP Research and Surveillance Centre: 50 years' surveillance of influenza, infections, and respiratory conditions"},{"title3":"Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile"},{"title3":"RCGP Research and Surveillance Centre Annual Report 2014-2015: disparities in presentations to primary care"},{"title3":"Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results"},{"title3":"Uptake of a dashboard designed to give realtime feedback to a sentinel network about key data required for influenza vaccine effectiveness studies"},{"title3":"Opportunities and challenges of a World Serum Bank"},{"title3":"Codes, classifications, terminologies and nomenclatures: definition, development and application in practice"},{"title3":"Administration of AS03B-adjuvanted A(H1N1)pdm09 vaccine in children aged &lt;3 years enhances antibody response to H3 and B viruses following a single dose of trivalent vaccine one year later"},{"title3":"Responses to live attenuated influenza vaccine in children vaccinated previously with Pandemrix (ASO3b&gt;Bb&gt; adjuvanted pandemic A/H1N1pdm09)"},{"title3":"Routinely collected general practice data: goldmines for research? A report of the European Federation for Medical Informatics Primary Care Informatics Working Group (EFMI PCIWG) from MIE2006, Maastricht, The Netherlands"},{"title3":"The CPRD and the RCGP: building on research success by enhancing benefits for patients and practices"},{"title3":"Privacy protection through pseudonymisation in eHealth"},{"title3":"Effective pseudonymisation and explicit statements of public interest to ensure the benefits of sharing health data for research, quality improvement and health service management outweigh the risks"},{"title3":"Information Governance Toolkit (IGT)"},{"title3":"List of materials considered to be 'relevant material' under the Human Tissue Act"},{"title3":"International charter of principles for sharing bio-specimens and data"},{"title3":"Clinical Informatics and Health Outcomes Research Group"},{"title3":"MRC Policy and guidance on sharing of research data from population and patient studies"},{"title3":"Promoting access to public research data for scientific, economic and social development"},{"title3":"Opportunities and challenges of a World Serum Bank - Authors' reply"},{"title3":"Estimates of the public health impact of a pediatric vaccination program using an intranasal tetravalent live-attenuated influenza vaccine in Belgium"},{"title3":"Uptake and impact of vaccinating school age children against influenza during a season with circulation of drifted influenza A and B strains, England, 2014/15"},{"title3":"Flu vaccination by pharmacists leads to suboptimal medical records"}]},{"title2":"Emergence of a novel coronavirus (COVID-19): protocol for extending surveillance used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England","References":[{"title3":"Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile"},{"title3":"RCGP Research and Surveillance Centre: 50 years' surveillance of influenza, infections, and respiratory conditions"},{"title3":"RCGP Research and Surveillance Centre Annual Report 2014-2015: disparities in presentations to primary care"},{"title3":"Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results"},{"title3":"Serological surveillance of influenza in an English sentinel network: pilot study protocol"},{"title3":"Ten years of serological surveillance in England and Wales: methods, results, implications and action"},{"title3":"Use of serological surveys to generate key insights into the changing global landscape of infectious disease"},{"title3":"Opportunities and challenges of a World Serum Bank"},{"title3":"Variation in the recording of diabetes diagnostic data in primary care computer systems: implications for the quality of care"},{"title3":"In this issue: Ontologies a key concept in informatics and key for open definitions of cases, exposures, and outcome measures"},{"title3":"An Ontology to Improve Transparency in Case Definition and Increase Case Finding of Infectious Intestinal Disease: Database Study in English General Practice"},{"title3":"Ontology to identify pregnant women in electronic health records: primary care sentinel network database study"},{"title3":"Self-sampling for community respiratory illness: a new tool for national virological surveillance"},{"title3":"Community Mitigation Guidelines to Prevent Pandemic Influenza - United States, 2017"},{"title3":"How will country-based mitigation measures influence the course of the COVID-19 epidemic?"},{"title3":"Approximate Bayesian computation for spatial SEIR(S) epidemic models"},{"title3":"Characterising seasonal influenza epidemiology using primary care surveillance data"},{"title3":"Approximate Bayesian computation scheme for parameter inference and model selection in dynamical systems"},{"title3":"Methods for estimating the case fatality ratio for a novel, emerging infectious disease"},{"title3":"Approximate Bayesian computational methods"},{"title3":"Novel Coronavirus Outbreak in Wuhan, China, 2020: Intense Surveillance Is Vital for Preventing Sustained Transmission in New Locations"},{"title3":"Covid-19: preparedness, decentralisation, and the hunt for patient zero"},{"title3":"Understanding of COVID-19 based on current evidence"},{"title3":"Lessons from 40 years' surveillance of influenza in England and Wales"},{"title3":"Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: results from a cohort study in general practice"}]},{"title2":"Household presentation of acute gastroenteritis in a primary care sentinel network: retrospective database studies","References":[{"title3":"Global, regional, and national causes of child mortality in 2008: a systematic analysis"},{"title3":"Potential causative agents of acute gastroenteritis in households with preschool children: prevalence, risk factors, clinical relevance and household incidence"},{"title3":"Societal burden and correlates of acute gastroenteritis in families with preschool children"},{"title3":"The second study of infectious intestinal disease (IID2): increased rates of recurrent diarrhoea in individuals aged 65 years and above"},{"title3":"Rotavirus vaccines: WHO position paper:January 2013"},{"title3":"Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted"},{"title3":"The vast and varied global burden of Norovirus: prospects for prevention and control"},{"title3":"Risk factors for symptomatic and asymptomatic norovirus infection in the community"},{"title3":"Transmission of acute gastroenteritis and respiratory illness from children to parents"},{"title3":"Incidence of household transmission of acute gastroenteritis (AGE) in a primary care sentinel network (1992-2017): cross-sectional and retrospective cohort study protocol"},{"title3":"RCGP research and surveillance Centre: 50 years' surveillance of influenza, infections, and respiratory conditions"},{"title3":"The use of routinely collected computer data for research in primary care: opportunities and challenges"},{"title3":"Uptake of a dashboard designed to give Realtime feedback to a sentinel network about key data required for influenza vaccine effectiveness studies"},{"title3":"An ontology to improve transparency in case definition and increase case finding of infectious intestinal disease: database study in English general practice"},{"title3":"Evaluation of obesity in school-age children"},{"title3":"Ethnicity Recording in Primary Care Computerised Medical Record Systems: An Ontological Approach"},{"title3":"English_Indices_of_Deprivation_2015_-_Frequently_Asked_Questions_Dec_2016.pdf URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/579151/. Accessed 20 Aug 2018."},{"title3":"Regression-based tests for overdispersion in the Poisson model"},{"title3":"Nested frailty models using maximum penalized likelihood estimation"},{"title3":"Interpreting hazard ratios"},{"title3":"Frailtypack: An r package for the analysis of correlated survival data with frailty models using penalized likelihood estimation or parametrical estimation"},{"title3":"High incidence of hospitalisation due to infectious gastroenteritis in older people associated with poor self-rated health"},{"title3":"Incidence of lower respiratory tract infections and atopic conditions in boys and young male adults: Royal College of general practitioners research and surveillance Centre annual report 2015-2016"},{"title3":"Culliney M, Haux T, McKay S. Family structure and poverty in the UK: An evidence and policy review&quot;. http://eprints.lincoln.ac.uk/14958/1/Family_structure_report_Lincoln.pdf. Accessed Aug 2019."},{"title3":"Hassan F, Kanwar N, Harrison CJ, Halasa NB, Chappell JD, Englund JA, et al. Viral etiology of acute gastroenteritis in &lt;2-year-old US children in the post-rotavirus vaccine era. J Pediatric Infect Dis Soc. 2018. 10.1093/jpids/piy077."},{"title3":"Blanden J, Del Bono K, Hansen S, McNally E, Rabe, B, Evaluating a demand-side approach to expanding free preschool education, Report presented as evidence to the House of Lords Select Committee on Affordable Childcare. University of Surrey, 2014. URL: https://www.iser.essex.ac.uk/files/projects/the-effect-of-free-childcare-on-maternal-labour-supply-and-child-development/childoutcomes.pdf. Accessed 18/06/2019."},{"title3":"Household transmission of acute gastroenteritis during the winter season in Japan"},{"title3":"Household transmission of gastroenteritis"},{"title3":"Acute diarrhea in adults consulting a general practitioner in France during winter: incidence, clinical characteristics, management and risk factors"},{"title3":"The unwelcome houseguest: secondary household transmission of norovirus"},{"title3":"Suspected Household transmission of Rotavirus in the United States"},{"title3":"Ejemot-Nwadiaro RI, Ehiri JE, Arikpo D, Meremikwu MM, Critchley JA. Hand washing promotion for preventing diarrhoea. Cochrane Database Syst Rev. 2015;(9):CD004265. 10.1002/14651858.CD004265.pub3."},{"title3":"The microbiological quality of washing-up water and the environment in domestic and commercial kitchens"},{"title3":"Cross-contamination in the kitchen: effect of hygiene measures"},{"title3":"Consumer-reported handling of raw poultry products at home: results from a national survey"},{"title3":"Older adults and parents of young children have different handling practices for raw poultry"},{"title3":"Wikswo ME, Parashar UD, Lopman B, Selvarangan R, Harrison CJ, Azimi PH, et al. Evidence for household incidence of rotavirus in the United States, 2011-2016. J Pediatric Infect Dis Soc. 2019. 10.1093/jpids/piz004."},{"title3":"Empirical examination of the indicator 'pediatric gastroenteritis hospitalization rate' based on administrative hospital data in Italy"},{"title3":"Gastroenteritis in childhood: a retrospective study of 650 hospitalized pediatric patients"},{"title3":"National Institute for Health Research School for primary care research. Clinical workload in UK primary care: a retrospective analysis of 100 million consultations in England, 2007-14"}]},{"title2":"Conurbation, urban, and rural living as determinants of allergies and infectious diseases: Royal College of General Practitioners Research and Surveillance Centre Annual Report 2016-2017","References":[{"title3":"Urbanisation and infectious diseases in a globalised world"},{"title3":"How urbanization affects the epidemiology of emerging infectious diseases"},{"title3":"Effects of climate change on environmental factors in respiratory allergic diseases"},{"title3":"The role of outdoor air pollution and climatic changes on the rising trends in respiratory allergy"},{"title3":"Occupational exposure to urban air pollution and allergic diseases"},{"title3":"A clear urban-rural gradient of allergic rhinitis in a population-based study in Northern Europe"},{"title3":"Socioeconomic and geographical variation in general practitioner consultations for allergic rhinitis in England, 2003-2014: an observational study"},{"title3":"The urban-rural gradient in asthma: a population-based study in northern Europe"},{"title3":"Air pollution, pollens, and daily admissions for asthma in London 1987-92"},{"title3":"Association between air pollutants and asthma emergency room visits and hospital admissions in time series studies: a systematic review and meta-analysis"},{"title3":"Pollen exposure and hospitalization due to asthma exacerbations: daily time series in a European city"},{"title3":"Progress in the impact of polluted meteorological conditions on the incidence of asthma"},{"title3":"Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile"},{"title3":"Surveillance of influenza-like illness in England and Wales during 1966-2006"},{"title3":"RCGP Research and Surveillance Centre: 50 years' surveillance of influenza, infections, and respiratory conditions"},{"title3":"End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17"},{"title3":"Codes, classifications, terminologies and nomenclatures: definition, development and application in practice"},{"title3":"Ethnicity recording in primary care computerised medical record systems: an ontological approach"},{"title3":"Breaking the first law of informatics: the quality and outcomes framework (QOF) in the dock"},{"title3":"The regression analysis of binary sequences"},{"title3":"Multiple comparisons"},{"title3":"Allergic rhinitis: a neglected disease - a community based assessment among adults in Delhi"},{"title3":"A tale of three cities: persisting high HIV prevalence, risk behaviour and undiagnosed infection in community samples of men who have sex with men"},{"title3":"Factors perceived to influence risky sexual behaviours among university students in the United Kingdom: a qualitative telephone interview study"},{"title3":"Risk factors for symptomatic urinary tract infection in women with diabetes"},{"title3":"Risk factors of urinary tract infection in pregnancy"},{"title3":"Risk factors for urinary tract infections in postmenopausal women"},{"title3":"Urban vs. rural factors that affect adult asthma"},{"title3":"Prevalence of self-reported asthma in urban and rural areas of Turkey"},{"title3":"Modifiable risk factors for acute lower respiratory tract infections"},{"title3":"Risk factors and viruses associated with hospitalization due to lower respiratory tract infections in Canadian Inuit children : a case-control study"},{"title3":"Risk factors for acute respiratory tract infections in under-five children in Enugu Southeast Nigeria"},{"title3":"Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities"},{"title3":"Do influenza and pneumococcal vaccines prevent community-acquired respiratory infections among older people with diabetes and does this vary by chronic kidney disease? A cohort study using electronic health records"},{"title3":"Urban and rural differences in parental attitudes about influenza vaccination and vaccine delivery models"},{"title3":"Influenza vaccination in old adults in Spain"},{"title3":"Are rural residents less likely to obtain recommended preventive healthcare services?"},{"title3":"Risk factors for sporadic Campylobacter infection: an all-Ireland case-control study"},{"title3":"Source attribution of human salmonellosis using a meta-analysis of case-control studies of sporadic infections"},{"title3":"Consumption patterns and preference of milk and milk products among rural and urban consumers in semi-arid Kenya"},{"title3":"Green spaces could reduce asthma admissions"},{"title3":"Is neighborhood green space protective against associations between child asthma, neighborhood traffic volume and perceived lack of area safety? Multilevel analysis of 4447 Australian children"},{"title3":"Greenness and allergies: evidence of differential associations in two areas in Germany"},{"title3":"Green areas around homes reduce atopic sensitization in children"},{"title3":"Uptake of a dashboard designed to give realtime feedback to a sentinel network about key data required for influenza vaccine effectiveness studies"},{"title3":"An educational intervention, involving feedback of routinely collected computer data, to improve cardiovascular disease management in UK primary care"}]},{"title2":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","References":[{"title3":"World Health Organization (WHO). Coronavirus. Geneva: WHO; 2020 [Accessed 21 Jan 2020]. Available from: https://www.who.int/health-topics/coronavirus "},{"title3":"Zhang Y-Z. Novel 2019 coronavirus genome. Virological. [Accessed 21 Jan 2020]. Available from: http://virological.org/t/novel-2019-coronavirus-genome/319 "},{"title3":"de Groot RJ, Baker SC, Baric R, Enjuanes L, Gorbalenya AE, Holmes KV, et al. Family Coronaviridae. In: King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ. Virus taxonomy: classification and nomenclature of viruses: ninth report of the International Committee on Taxonomy of Viruses. London; Waltham: Academic Press; 2012. p. 806-20."},{"title3":"The severe acute respiratory syndrome."},{"title3":"World Health Organization. (WHO. Novel Coronavirus (2019-nCoV). Situation report - 1. Geneva: WHO; 21 Jan 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf "},{"title3":"SARS testing: First past the post."},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Specific detection by real-time reverse-transcription PCR assays of a novel avian influenza A(H7N9) strain associated with human spillover infections in China."},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction."},{"title3":"Coordinated implementation of chikungunya virus reverse transcription-PCR."},{"title3":"Assay optimization for molecular detection of Zika virus."},{"title3":"Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences."},{"title3":"Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission."},{"title3":"Hosts and sources of endemic human coronaviruses."},{"title3":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS."},{"title3":"Origin and evolution of pathogenic coronaviruses."},{"title3":"The European Virus Archive goes global: A growing resource for research."},{"title3":"Developing a framework to assess the costeffectiveness of COMPARE - a global platform for the exchange of sequence-based pathogen data."},{"title3":"Need for additional capacity and improved capability for molecular detection of yellow fever virus in European Expert Laboratories: External Quality Assessment, March 2018."},{"title3":"First international external quality assessment of molecular diagnostics for Mers-CoV."},{"title3":"Advancing preparedness for clinical research during infectious disease epidemics."}]},{"title2":"Guidance and standard operating procedure: COVID-19 virus testing in NHS laboratories","References":[]},{"title2":"COVID-19 Surveillance Ontology","References":[{"title3":"Understanding health care as a complex system: the foundation for unintended consequences"},{"title3":"Understanding health care delivery as a complex system: achieving best possible health outcomes for individuals and communities by focusing on interdependencies"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"Novel Coronavirus(2019-nCoV) Situation Report - 10"},{"title3":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses - a statement of the Coronavirus Study Group"},{"title3":"Novel Coronavirus (2019-nCoV) Situation Report - 22"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study"},{"title3":"Real estimates of mortality following COVID-19 infection"},{"title3":"Estimates of the severity of coronavirus disease 2019: a model-based analysis"},{"title3":"To monitor the COVID-19 pandemic we need better quality primary care data"},{"title3":"In this issue: Ontologies a key concept in informatics and key for open definitions of cases, exposures, and outcome measures"},{"title3":"Domain Ontologies in Software Engineering: Use of Protege with the EON Architecture"},{"title3":"Reference and Application Ontologies"},{"title3":"Using Unified Modelling Language (UML) as a process-modelling technique for clinical-research process improvement"},{"title3":"Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile"},{"title3":"RCGP Research and Surveillance Centre: 50 years' surveillance of influenza, infections, and respiratory conditions"},{"title3":"Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results"},{"title3":"Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England"},{"title3":"PRINCIPLE: A trial evaluating treatments for suspected COVID-19 in people aged 50 years and above with pre-existing conditions and those aged 65 years and above"},{"title3":"An ontological approach to identifying cases of chronic kidney disease from routine primary care data: a cross-sectional study"},{"title3":"Ontology to identify pregnant women in electronic health records: primary care sentinel network database study"},{"title3":"Investigating regional variation of respiratory infections in a general practice syndromic surveillance system"},{"title3":"Automated differentiation of incident and prevalent cases in primary care computerised medical records (CMR)"},{"title3":"Big Data Usage Patterns in the Health Care Domain: A Use Case Driven Approach Applied to the Assessment of Vaccination Benefits and Risks. Contribution of the IMIA Primary Healthcare Working Group"},{"title3":"A method of identifying and correcting miscoding, misclassification and misdiagnosis in diabetes: a pilot and validation study of routinely collected data"},{"title3":"Variation in the recording of diabetes diagnostic data in primary care computer systems: implications for the quality of care"},{"title3":"The FAIR Guiding Principles for scientific data management and stewardship"},{"title3":"The Protege Project: A Look Back and a Look Forward"},{"title3":"OWL Web Ontology Language Overview: W3C Recommendation"},{"title3":"Ethical Use of Electronic Health Record Data and Artificial Intelligence: Recommendations of the Primary Care Informatics Working Group of the International Medical Informatics Association"},{"title3":"Artificial Intelligence in Primary Health Care: Perceptions, Issues, and Challenges"},{"title3":"Legal bases for disclosing confidential patient information for public health: Distinguishing between health protection and health improvement"},{"title3":"RCGP RSC COVID-19 Surveillance"},{"title3":"RCGP RSC COVID-19 Practice-Level Dashboard"},{"title3":"COVID-19 Observatory"},{"title3":"Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study"},{"title3":"COVID-19 Surveillance Ontology"},{"title3":"Global surveillance for COVID-19 caused by human infection with COVID-19 virus: Interim guidance"},{"title3":"Clinical guidance on COVID-19 SNOMED codes"},{"title3":"The Oxford Royal College of General Practitioners Clinical Informatics Digital Hub: Protocol to Develop Extended COVID-19 Surveillance and Trial Platforms"},{"title3":"Modeling sample variables with an Experimental Factor Ontology"},{"title3":"Computer-assisted update of a consumer health vocabulary through mining of social network data"},{"title3":"Social media and internet-based data in global systems for public health surveillance: a systematic review"},{"title3":"BioCaster: detecting public health rumors with a Web-based text mining system"},{"title3":"Big Data and the Global Public Health Intelligence Network (GPHIN)"},{"title3":"ProMED-mail: an early warning system for emerging diseases"},{"title3":"HealthMap: Global Infectious Disease Monitoring through Automated Classification and Visualization of Internet Media Reports"},{"title3":"Epidemic Intelligence from Open Sources (EIOS)"},{"title3":"SSO: The Syndromic Surveillance Ontology"},{"title3":"Ontology-Centered Syndromic Surveillance for Bioterrorism"},{"title3":"Improving epidemic surveillance and response: big data is dead, long live big data"},{"title3":"Coronavirus Infectious Disease Ontology"},{"title3":"WHO COVID-19 Rapid Version CRF semantic data model"},{"title3":"Common Data Models (CDMs) to Enhance International Big Data Analytics: A Diabetes Use Case to Compare Three CDMs"}]},{"title2":"Coronavirus (COVID-19): notice under reg 3(4) of the Health Service Control of Patient Information Regulations 2002:general","References":[]},{"title2":"Defining research table","References":[]},{"title2":"Ethnicity recording in primary care computerised medical record systems: an ontological approach","References":[]},{"title2":"The English Index of Multiple Deprivation (IMD) 2015:Guidance","References":[]},{"title2":"Multivariate imputation by chained equations in R","References":[]},{"title2":"Construction and assessment of prediction rules for binary outcome in the presence of missing predictor data using multiple imputation and cross-validation: methodological approach and data-based evaluation","References":[{"title3":"On the necessity and design of studies comparing statistical methods"},{"title3":"Bagging predictors"},{"title3":"Multiple imputation by chained equations in R"},{"title3":"Bayesian imputation of time-varying covariates in linear mixed models"},{"title3":"Dealing with missing covariates in epidemiological studies: A comparison between multiple imputation and a full Bayesian approach"},{"title3":"Usefulness of the CRT-SCORE for shared decision making in cardiac resynchronization therapy in patients with a left ventricular ejection fraction of &lt;=35"},{"title3":"Joint modelling rationale for chained equations imputation"},{"title3":"Combining estimates of interest in prognostic modelling studies after multiple imputation: Current practice and guidelines"},{"title3":"Missing data and prediction: The pattern submodel"},{"title3":"Obtaining predictions from models fit to multiply imputed data"},{"title3":"Risk factors for treatment failure after allogeneic transplantation of patients with CLL: A report from the European Society for Blood and Marrow Transplantation"},{"title3":"Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: A retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT)"},{"title3":"Development and validation of a prediction model with missing predictor data: A practical approach"},{"title3":"Assessment of predictive performance in incomplete data by combining internal validation and multiple imputation"},{"title3":"Stacked generalization"},{"title3":"The estimation and use of predictions for the assessment of model performance using large samples with multiply imputed data"}]},{"title2":"KS201EW: ethnic group","References":[{"title3":"Increased support for political compromise in the Israeli-Palestinian conflict following an 8-week mindfulness workshop"},{"title3":"The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations"},{"title3":"These things called empathy: Eight related but distinct phenomena"},{"title3":"The empathy-altruism hypothesis: Issues and implications"},{"title3":"Distress and empathy: Two qualitatively distinct vicarious emotions with different motivational consequences"},{"title3":"The empathy:Altruism hypothesis"},{"title3":"Closing the empathy gap: A narrative review of the measurement and reduction of parochial empathy"},{"title3":"Berger, R., Brenick, A., &amp; Tarrasch, R. (2018). Reducing Israeli-Jewish pupils' outgroup prejudice with a mindfulness and compassion-based social-emotional program. Mindfulness, 9(6), 1768-1779. 10.1007/s12671-018-0919-y"},{"title3":"Reducing separateness with presence: How mindfulness catalyzes intergroup prosociality"},{"title3":"Mindfulness increases prosocial responses toward ostracized strangers through empathic concern"},{"title3":"Does mindfulness training without explicit ethics-based instruction promote prosocial behaviors? A meta-analysis"},{"title3":"Berry, D. R., Rodriguez, K., Tasulis, G., &amp; Behler, A. M. C. (2022). Mindful attention as a skillful means toward intergroup prosociality. Mindfulness. 10.1007/s12671-022-01926-3"},{"title3":"Short-term training in mindfulness predicts helping behavior toward racial ingroup and outgroup members"},{"title3":"Mindfulness enhances episodic memory performance: Evidence from a multimethod investigation"},{"title3":"When what one has is enough: Mindfulness, financial desire discrepancy, and subjective well-being"},{"title3":"The benefits of being present: Mindfulness and its role in psychological well-being"},{"title3":"Minding the gap: Narrative descriptions about mental states attenuate parochial empathy"},{"title3":"Parochial empathy predicts reduced altruism and the endorsement of passive harm"},{"title3":"Empathy is hard work: People choose to avoid empathy because of its cognitive costs"},{"title3":"Their pain gives us pleasure: How intergroup dynamics shape empathic failures and counter-empathic responses"},{"title3":"Us and them: Intergroup failures of empathy"},{"title3":"Meditation increases compassionate responses to suffering"},{"title3":"Empirical explorations of mindfulness: Conceptual and methodological conundrums"},{"title3":"A multidimensional approach to individual differences in empathy"},{"title3":"Measuring individual differences in empathy: Evidence for a multidimensional approach"},{"title3":"The functional architecture of human empathy"},{"title3":"Compassion and altruism: How our minds determine who is worthy of help"},{"title3":"&quot;Let them eat harmony&quot;: Prejudice-reduction strategies and attitudes of historically disadvantaged groups"},{"title3":"Does your mindfulness benefit others? A systematic review and meta-analysis of the link between mindfulness and prosocial behaviour"},{"title3":"Toward an understanding of non-dual mindfulness"},{"title3":"On the universality and cultural specificity of emotion recognition: A meta-analysis"},{"title3":"Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses"},{"title3":"Differential effects of mindful breathing, progressive muscle relaxation, and loving-kindness meditation on decentering and negative reactions to repetitive thoughts"},{"title3":"Empathic concern drives costly altruism"},{"title3":"Frost, K. (2017). Calming meditation increases altruism, decreases parochialism. bioRxiv. 10.1101/060616"},{"title3":"Why it pays to get inside the head of your opponent: The differential effects of perspective taking and empathy in negotiations"},{"title3":"Intergroup differences in the sharing of emotive states: Neural evidence of an empathy gap"},{"title3":"Helping people by being in the present: Mindfulness increases prosocial behavior"},{"title3":"Empathy as a peace catalyst in intractable conflict: Is it feasible? Is it enough?"},{"title3":"Are liberals and conservatives equally motivated to feel empathy toward others?"},{"title3":"Dimensions of contact as predictors of intergroup anxiety, perceived out-group variability, and out-group attitude: An integrative model"},{"title3":"Mindfulness-based interventions in context: Past, present, and future"},{"title3":"The nondiscriminating heart: Lovingkindness meditation training decreases implicit intergroup bias"},{"title3":"Mindfulness training increases cooperative decision making in economic exchanges: Evidence from fMRI"},{"title3":"The limited prosocial effects of meditation: A systematic review and meta-analysis"},{"title3":"The ascent of man: Theoretical and empirical evidence for blatant dehumanization"},{"title3":"The evolution of altruism in humans"},{"title3":"Short-term compassion training increases prosocial behavior in a newly developed prosocial game"},{"title3":"Lippelt, D. P., Hommel, B., &amp; Colzato, L. S. (2014). Focused attention, open monitoring and loving kindness meditation: Effects on attention, conflict monitoring, and creativity - A review. Frontiers in Psychology, 5. 10.3389/fpsyg.2014.01083"},{"title3":"Least squares quantization in PCM"},{"title3":"Mindfulness meditation reduces implicit age and race bias: The role of reduced automaticity of responding"},{"title3":"Brief mindfulness meditation reduces discrimination"},{"title3":"Investigating the phenomenological matrix of mindfulness-related practices from a neurocognitive perspective"},{"title3":"Intergroup emotions and intergroup relations"},{"title3":"Some methods for classification and analysis of multivariate observations"},{"title3":"Caring about carelessness: Participant inattention and its effects on research"},{"title3":"Mindfulness and intergroup bias: A systematic review"},{"title3":"The effects of a self-observation-based meditation intervention on acceptance or rejection of the other"},{"title3":"The irony of harmony: Intergroup contact can produce false expectations for equality"},{"title3":"Dispositional mindfulness moderates the association between social value orientation and in-group love and out-group hate"},{"title3":"Overlap of self, ingroup, and outgroup: Pictorial measures of self-categorization"},{"title3":"Effects of an 8-week mindfulness course on affective polarization"},{"title3":"Bridging the (Brexit) divide: Effects of a brief befriending meditation on affective polarization"},{"title3":"Love thy (partisan) neighbor: Brief befriending meditation reduces affective polarization"},{"title3":"The social neuroscience of empathy"},{"title3":"Brief loving-kindness meditation reduces racial bias, mediated by positive other-regarding emotions"},{"title3":"Brief mindfulness meditation improves mental state attribution and empathizing"},{"title3":"The neuroscience of mindfulness meditation"},{"title3":"Mindful attention reduces linguistic intergroup bias"},{"title3":"Compassion training alters altruism and neural responses to suffering"},{"title3":"Empathy: A motivated account"},{"title3":"Addressing empathic failures"}]},{"title2":"Census geography: 2001 output areas","References":[]},{"title2":"COVID-19: what has been learned and to be learned about the novel coronavirus disease","References":[]},{"title2":"Epidemiology of 2019 novel coronavirus in Jiangsu Province, China after wartime control measures: a population-level retrospective study","References":[{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"The press conference on COVID-19 in Hubei"},{"title3":"Six weeks into the 2019 coronavirus disease (COVID-19) outbreak- it is time to consider strategies to impede the emergence of new zoonotic infections"},{"title3":"COVID-19: fighting panic with information"},{"title3":"A confirmed COVID-19 case in Suzhou was reported by the national health and Health Commission"},{"title3":"Presumed asymptomatic carrier transmission of COVID-19"},{"title3":"Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19"},{"title3":"Novel coronavirus (2019-nCoV) cases in Hong Kong and implications for further spread"},{"title3":"Potential presymptomatic transmission of SARS-CoV-2, Zhejiang province, China, 2020"},{"title3":"COVID-19 control in China during mass population movements at New Year"},{"title3":"Facing the COVID-19 outbreak: what should we know and what could we do?"},{"title3":"The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?"},{"title3":"Passengers' destinations from China: low risk of novel coronavirus (2019-nCoV) transmission into Africa and South America"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges"},{"title3":"The number of confirmed COVID-19 case was reported by the national health and Health Commission"}]},{"title2":"Investigating regional variation of respiratory infections in a general practice syndromic surveillance system","References":[]},{"title2":"Coronavirus (COVID-19) roundup","References":[]},{"title2":"Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China"},{"title3":"Coronavirus disease (COVID-19) situation reports"},{"title3":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application"},{"title3":"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school"},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome"},{"title3":"Estimating the severity and subclinical burden of Middle East respiratory syndrome coronavirus infection in the Kingdom of Saudi Arabia"},{"title3":"Analysis of coarsely observed data [R package coarseDataTools version 0 6-5]. Version 0.6-5"},{"title3":"Estimating incubation period distributions with coarse data"},{"title3":"Estimating absolute and relative case fatality ratios from infectious disease surveillance data"},{"title3":"A leisurely look at the bootstrap, the jackknife, and cross-validation"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia"},{"title3":"Report 3: transmissibility of 2019-nCoV"},{"title3":"Sensitivity of chest CT for COVID-19: comparison to RT-PCR"}]},{"title2":"Ethnicity and COVID-19: an urgent public health research priority","References":[{"title3":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"&quot;Race&quot; and &quot;ethnicity&quot; in biomedical research: How do scientists construct and explain differences in health?"},{"title3":"Ethnicity, deprivation and mortality due to 2009 pandemic influenza A(H1N1) in England during the 2009/2010 pandemic and the first post-pandemic season"},{"title3":"UK government urged to investigate coronavirus deaths of BAME doctors"},{"title3":"Coronavirus cases to be tracked by ethnicity"},{"title3":"The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans"}]},{"title2":"ICNARC report on COVID-19 in critical care","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Case mix, outcome and length of stay for admissions to adult, general critical care units in England, Wales and Northern Ireland: the Intensive Care National Audit &amp; Research Centre Case Mix Programme Database"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Development and validation of the new ICNARC model for prediction of acute hospital mortality in adult critical care"},{"title3":"APACHE II: a severity of disease classification system"},{"title3":"Early observational research and registries during the 2009-2010 influenza A pandemic"},{"title3":"The Swine Flu Triage (SwiFT) study: development and ongoing refinement of a triage tool to provide regular information to guide immediate policy and practice for the use of critical care services during the H1N1 swine influenza pandemic"},{"title3":"Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study"},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"Clinical characteristics of patients who died of Coronavirus Disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"}]},{"title2":"Population of England and Wales","References":[]},{"title2":"Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis","References":[{"title3":"US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008"},{"title3":"Trends in hypertension prevalence, awareness, treatment, and control in older U.S. Adults: Data from the National Health and Nutrition Examination Survey 1988 to 2004"},{"title3":"Studies of blood pressures in children, ages 5-14 years, in a total biracial community: The Bogalusa Heart Study"},{"title3":"Epidemiology of hypertension from childhood to young adulthood in black, white, and hispanic population samples"},{"title3":"Ten-year incidence of elevated blood pressure and its predictors: The CARDIA Study. Coronary Artery Risk Development in (Young) Adults"},{"title3":"Race and sex differentials in the impact of hypertension in the united states. The National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study"},{"title3":"Seven-year incidence of hypertension in a cohort of middle-aged African Americans and whites"},{"title3":"Incidence and correlates of hypertension in the Atherosclerosis Risk in Communities (ARIC) study and the Monitoring Trends and Determinants of Cardiovascular Disease (POL-MONICA) project"},{"title3":"Decreased prevalence of hypertension in Mexican-Americans"},{"title3":"Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004"},{"title3":"Blood pressure in Mexican Americans, whites, and blacks. The Second National Health and Nutrition Examination Survey and the Hispanic Health and Nutrition Examination Survey"},{"title3":"Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000"},{"title3":"Racial/ethnic variation in hypertension-related lifestyle behaviours among US women with self-reported hypertension"},{"title3":"Cardiovascular risk factors among Asian Americans: Results from a national health survey"},{"title3":"Ethnic variation in hypertension among premenopausal and perimenopausal women: Study of Women's Health Across the Nation"},{"title3":"Eight-year incidence of hypertension in Mexican-Americans and non-Hispanic whites. The San Antonio Heart Study"},{"title3":"Multi-ethnic Study of Atherosclerosis: objectives and design"},{"title3":"The CES-D scale"},{"title3":"Validation of a self-administered diet history questionnaire using multiple diet records"},{"title3":"A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group"},{"title3":"Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The practical incidence estimators (pie) macro"},{"title3":"Prevalence of cardiovascular disease risk factors in blacks and whites: The Minnesota Heart Survey"},{"title3":"Black/white differences in hypertension in the elderly: An epidemiologic analysis in central north carolina"},{"title3":"Racial/ethnic differences in hypertension and hypertension treatment and control in the Multi-ethnic Study of Atherosclerosis (MESA)"},{"title3":"Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: The Bogalusa Heart Study"},{"title3":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure"},{"title3":"Alcohol consumption and the incidence of hypertension: The Atherosclerosis Risk in Communities Study"},{"title3":"Prevalence of hypertension in Hispanic and non-Hispanic white populations"},{"title3":"Patterns and predictors of hypertension incidence among Hispanics and non-Hispanic whites: The San Luis Valley Diabetes Study"},{"title3":"Association between selected unhealthy lifestyle factors, body mass index, and chronic health conditions among individuals 50 years of age or older, by race/ethnicity"},{"title3":"Acculturation is associated with hypertension in a multiethnic sample"},{"title3":"Cardiovascular risk factors among Asian Americans living in northern California"},{"title3":"Defining and setting national goals for cardiovascular health promotion and disease reduction: The American Heart Association's strategic impact goal through 2020 and beyond"},{"title3":"Effects of comprehensive lifestyle modification on blood pressure control: Main results of the Premier clinical trial"},{"title3":"Primary prevention of hypertension: Clinical and public health advisory from the national high blood pressure education program"}]},{"title2":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","References":[{"title3":"Risk factors for primary middle east respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Tuberculosis and diabetes mellitus: convergence of two epidemics"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA Score"},{"title3":"Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011-2012: Hospital-based Influenza Morbidity &amp; Mortality (HIMM) surveillance"},{"title3":"Summary of the 2018 report on cardiovascular diseases in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"Burden of diabetes, hyperglycaemia in China from to 2016: findings from the 1990 to 2016, global burden of disease study"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis"},{"title3":"Connecting type 1 and type 2 diabetes through innate immunity"},{"title3":"Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak - United States, December 31, 2019-February 4, 2020"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China, 2020"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing"}]},{"title2":"CKD and the risk of acute, community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using electronic health records","References":[{"title3":"Is secondary preventive care improving? Observational study of 10-year trends in emergency admissions for conditions amenable to ambulatory care"},{"title3":"Increasing hospital admissions for pneumonia, England"},{"title3":"CKD and risk of hospitalization and death with pneumonia"},{"title3":"US Renal Data System 2010 Annual Data Report"},{"title3":"Risk of bloodstream infection in patients with chronic kidney disease not treated with dialysis"},{"title3":"Incidence and predictors of hospitalization for bacterial infection in community-based patients with type 2 diabetes: the Fremantle Diabetes Study"},{"title3":"Asymptomatic bacteriuria as a predictor of subsequent hospitalisation with urinary tract infection in diabetic adults: the Fremantle Diabetes Study"},{"title3":"Epidemiology, clinical features and outcomes of pneumonia in patients with chronic kidney disease"},{"title3":"Identification of new risk factors for pneumonia: population-based case-control study"},{"title3":"Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice"},{"title3":"Identification and management of chronic kidney disease"},{"title3":"United States Renal Data System 2011 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States"},{"title3":"Effects of pay for performance on the quality of primary care in England"},{"title3":"New estimates of the burden of acute community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using linked electronic health records"},{"title3":"The Association of Public Health Observatories (APHO) diabetes prevalence model: estimates of total diabetes prevalence for England, 2010-2030"},{"title3":"Identification of risk factors associated with acute kidney injury in patients admitted to acute medical units"},{"title3":"CPRD. The Clinical Practice Research Datalink-CPRD. 2012. http://www.cprd.com/intro.asp. Accessed August 30, 2012."},{"title3":"Validation and validity of diagnoses in the General Practice Research Database: a systematic review"},{"title3":"The UK General Practice Research Database"},{"title3":"The Health and Social Care Information Centre. HESonline. 2012. http://www.hscic.gov.uk/hes. Accessed September 14, 2012."},{"title3":"Office for National Statistics. 2012. www.ons.gov.uk. Accessed September 14, 2012."},{"title3":"A new equation to estimate glomerular filtration rate"},{"title3":"Comparison of risk prediction using the CKD-EPI equation and the MDRD Study equation for estimated glomerular filtration rate"},{"title3":"National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification"},{"title3":"Completeness and usability of ethnicity data in UK-based primary care and hospital databases"},{"title3":"Creatinine fluctuation has a greater effect than the formula to estimate glomerular filtration rate on the prevalence of chronic kidney disease"},{"title3":"Incidence of community-acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population-based study"},{"title3":"The English smoking treatment services: one-year outcomes"},{"title3":"The validity of searching routinely collected general practice computer data to identify patients with chronic kidney disease (CKD): a manual review of 500 medical records"},{"title3":"Referral patterns to renal services: what has changed in the past 4 years?"},{"title3":"NHS Employers. Quality and outcomes framework. 2012. http://www.nhsemployers.org/payandcontracts/generalmedicalservicescontract/qof/pages/qualityoutcomesframework.aspx. Accessed September 12, 2012."},{"title3":"The risk of infection-related hospitalization with decreased kidney function"},{"title3":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization"},{"title3":"Overview of vaccination in chronic kidney disease"}]},{"title2":"Short- and long-term outcomes after incident pneumonia in adults with chronic kidney disease: a time-dependent analysis from the Stockholm CREAtinine Measurement project","References":[{"title3":"Community-acquired pneumonia"},{"title3":"Clinical and economic burden of community-acquired pneumonia among adults in Europe"},{"title3":"Community-acquired pneumonia requiring hospitalization among U.S. adults"},{"title3":"Community-acquired pneumonia"},{"title3":"Respiratory health and disease in Europe: the new European Lung White Book"},{"title3":"Incremental risk of long-term mortality with increased burden of comorbidity in hospitalized patients with pneumonia"},{"title3":"Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis"},{"title3":"A non-human primate model of severe pneumococcal pneumonia"},{"title3":"Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia"},{"title3":"Invasive pneumococcal disease leads to activation and hyperreactivity of platelets"},{"title3":"Cardiotoxicity during invasive pneumococcal disease"},{"title3":"CKD and risk for hospitalization with infection: the atherosclerosis risk in communities (ARIC) study"},{"title3":"eGFR and the risk of community-acquired infections"},{"title3":"US renal data system 2017 annual data report: epidemiology of kidney disease in the United States"},{"title3":"Chronic kidney disease as a risk factor for acute community-acquired infections in high-income countries: a systematic review"},{"title3":"Risk of pneumonia among patients with chronic kidney disease in outpatient and inpatient settings: a nationwide population-based study"},{"title3":"CKD and risk of hospitalization and death with pneumonia"},{"title3":"Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival"},{"title3":"Non-enteropathic hemolytic uremic syndrome: causes and short-term course"},{"title3":"Sustained activation of Wnt/beta-catenin signaling drives AKI to CKD Progression"},{"title3":"Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study"},{"title3":"Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA)"},{"title3":"Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study"},{"title3":"The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness"},{"title3":"KDOQI clinical practice guideline for diabetes and CKD: 2012 update"},{"title3":"Cause of death in patients with reduced kidney function"},{"title3":"Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013"},{"title3":"Epidemiology, clinical features and outcomes of pneumonia in patients with chronic kidney disease"},{"title3":"Incidence and prognostic implications of acute kidney injury on admission in patients with community-acquired pneumonia"},{"title3":"Increased risk of acute kidney injury following pneumococcal pneumonia: a nationwide cohort study"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies"},{"title3":"Pneumococcal pneumonia infection is associated with end-stage renal disease in adult hospitalized patients"},{"title3":"Hospital admission with pneumonia and subsequent persistent risk of chronic kidney disease: national cohort study"},{"title3":"Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice"},{"title3":"The etiology of glomerulonephritis: roles of infection and autoimmunity"},{"title3":"Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines"},{"title3":"Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study"},{"title3":"Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis"},{"title3":"Role of acute infection in triggering acute coronary syndromes"},{"title3":"Platelet activation is associated with myocardial infarction in patients with pneumonia"},{"title3":"Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths"},{"title3":"The role of macrolide antibiotics in increasing cardiovascular risk"},{"title3":"Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia"},{"title3":"Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis"},{"title3":"Infection in advanced chronic kidney disease leads to increased risk of cardiovascular events, end-stage kidney disease and mortality"},{"title3":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease"},{"title3":"Mortality of dialysis patients according to influenza and pneumococcal vaccination status"},{"title3":"The association of pneumococcal vaccination with hospitalization and mortality in hemodialysis patients"},{"title3":"External review and validation of the Swedish national inpatient register"},{"title3":"Accuracy of ICD-9-CM codes in identifying infections of pneumonia and herpes simplex virus in administrative data"}]},{"title2":"Obesity and respiratory diseases","References":[]},{"title2":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"WHO Coronavirus (COVID-19) Dashboard"},{"title3":"Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: A systemic review and meta-analysis"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Coronavirus disease 2019 case surveillance - United States"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel Coronavirus diseases (COVID-19) - China"},{"title3":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC"},{"title3":"Hypothesis: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19"},{"title3":"Extrapulmonary manifestations of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target"},{"title3":"Preventing a COVID-19 pandemic"},{"title3":"SARS-CoV2: Should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?"},{"title3":"Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and risk of COVID-19"},{"title3":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China"},{"title3":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)"},{"title3":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: A prospective, randomised, open-label trial"},{"title3":"Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): A prospective, parallel group, randomised, controlled, open-label trial"},{"title3":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: A randomized clinical trial"},{"title3":"Effects of renin-angiotensin-aldosterone inhibitors on early outcomes of hypertensive COVID-19 patients: A randomized triple-blind clinical trial"},{"title3":"The use of propensity score methods with survival or time-to-event outcomes: Reporting measures of effect similar to those used in randomized experiments"},{"title3":"Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes"},{"title3":"Comparison of evidence of treatment effects in randomized and nonrandomized studies"},{"title3":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews"},{"title3":"The cochrane collaboration's tool for assessing risk of bias in randomised trials"},{"title3":"Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; 2021. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp."},{"title3":"Measuring inconsistency in meta-analyses"},{"title3":"Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis"},{"title3":"Effects of recent use of renin-angiotensin system inhibitors on mortality of patients with coronavirus disease 2019"},{"title3":"Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: A retrospective cohort study"},{"title3":"Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans"},{"title3":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: A retrospective observational study"},{"title3":"Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension"},{"title3":"The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension"},{"title3":"Clinical features of COVID-19 in patients with essential hypertension and the impacts of renin-angiotensin-aldosterone system inhibitors on the prognosis of COVID-19 patients"},{"title3":"Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea"},{"title3":"A retrospective study from 2 centers in China on the effects of continued use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with hypertension and COVID-19"},{"title3":"Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: A retrospective observational study"},{"title3":"Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis"},{"title3":"Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: A systematic review and meta-analysis"},{"title3":"Associations between the use of renin-angiotensin system inhibitors and the risks of severe COVID-19 and mortality in COVID-19 patients with hypertension: A meta-analysis of observational studies"},{"title3":"Mortality and severity in COVID-19 patients on ACEIs and ARBs - A systematic review, meta-analysis, and meta-regression analysis"},{"title3":"Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults: A living systematic review"},{"title3":"Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF program"}]},{"title2":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19","References":[{"title3":"Physiology of local renin-angiotensin systems."},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus."},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin."},{"title3":"Pharmacologic modulation of ACE2 expression."},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2."},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19."},{"title3":"Renin-angiotensin system blockers and the COVID-19 pandemic."},{"title3":"Angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patients."},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China."},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?"},{"title3":"HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19"},{"title3":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?"},{"title3":"Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19."},{"title3":"Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes."},{"title3":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial."},{"title3":"Incidence, predictors, and outcomes associated with hypotensive episodes among heart failure patients receiving sacubitril/valsartan or enalapril: the PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure)."},{"title3":"Coronavirus emergency."},{"title3":"Early cardiovascular protection by initial two-drug fixed-dose combination treatment vs. monotherapy in hypertension."},{"title3":"Generating evidence from computerized healthcare utilization databases."},{"title3":"Adherence with antihypertensive drug therapy and the risk of heart failure in clinical practice."},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"A new population-based risk stratification tool was developed and validated for predicting mortality, hospital admissions, and health care costs."},{"title3":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy."}]},{"title2":"Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19","References":[]},{"title2":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)","References":[]},{"title2":"COVID-19 and smoking: a systematic review of the evidence","References":[{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72.314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis"},{"title3":"COVID-19 and smoking: A systematic review of the evidence"},{"title3":"COVID-19 and smoking"},{"title3":"Patanavanich R, Glantz SA. Smoking is associated with COVID-19 progression: A meta-analysis. medRxiv preprint. doi: https://doi.org/10.1101/2020.04.13.20063669"},{"title3":"The impact of COPD and smoking history on the severity of Covid-19: A systemic review and meta-analysis"},{"title3":"Schopfel J. Towards a Prague definition of grey literature. Twelfth International Conference on Grey Literature: Transparency in Grey Literature. Grey Tech Approaches to High Tech Issues. Prague, 6-7 December 2010, Dec 2010, Czech Republic. pp. 11-26. sic_00581570 [consultado30 Abr 2020]. Disponible en: https://archivesic.ccsd.cnrs.fr/sic_00581570/document"},{"title3":"The PRISMA Group, Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement"},{"title3":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration"},{"title3":"Meta-analysis in clinical trials"},{"title3":"Diagnosis and treatment of adults with community-acquired pneumonia: An official clinical practice guideline of the American Thoracic Society and Infectious Disease Society of America"},{"title3":"Evidence-based medicine chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"},{"title3":"Review Manager (RevMan) [programa informatico]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014."},{"title3":"Prevalence of underlying diseases in hospitalized patients with COVID-19: A systematic review and meta-analysis"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Hu L, Chen S, Fu Y, Gao Z, Long H, Ren HW, et al. Risk factors associated with clinical outcomes in 323 COVID-19 patients in Wuhan, China. medRxiv preprint. doi: https://doi.org/10.1101/2020.03.25.20037721"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study"},{"title3":"ACE-2 expression in the small airway epithelia of smokers and COPD patients: Implications for COVID-19"},{"title3":"Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China"},{"title3":"Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)"},{"title3":"Ma Ch, Gu J, Hou P, Zhang L, Bai Y, Guo Z, et al. Incidence, clinical characteristics and prognostic factor of patients with COVID-19: A systematic review and meta-analysis. medRxiv preprint doi: https://doi.org/10.1101/2020.03.17.20037572."},{"title3":"Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease"},{"title3":"Wu C, Hu X, Song J, Du Ch, Xu J, Yang D, et al. Heart injury signs are associated with higher and earlier mortality in coronavirus disease 2019 (COVID-19). medRxiv preprint doi: https://doi.org/10.1101/2020.02.26.20028589."},{"title3":"Smoking, vaping and hospitalization for COVID-19"},{"title3":"COVID-19 with different severity: A multi-center study of clinical features"},{"title3":"Clinical feature of COVID-19 in elderly patients: A comparison with young and middle-aged patients"},{"title3":"Shu L, Wang X, Li M, Chen X, Shi L, Wu M, et al. Clinical characteristics of 545 cases confirmed COVID-19 in Wuhan Stadium Cabin Hospital. [consultado 1 May 2020]. Disponible en: https://ssrn.com/abstract=3552844 o http://dx.doi.org/102139/ssrn.3552844"},{"title3":"Comorbidity and its impact on 1590 patients with Covid-19 in China: A nationwide analysis"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Qi D, Yan X, Tang X, Peng J, Yu Q, Feng L, et al. Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality, China: A retrospective, descriptive, multiple-center study. medRxiv preprint. doi: https://doi.org/10.1101/2020.03.01.20029397"},{"title3":"Epidemiological and clinical features of 125 hospitalized patients with COVID-19 in Fuyang, Anhui, China"},{"title3":"CDC COVID-19 Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019-United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep. 20203;69(13):382-386. doi: 10.15585/mmwr.mm6913e2."},{"title3":"Clinical course and outcomes of patients with severe acute respiratory syndrome coronavirus 2 infection: A preliminary report of the first 28 patients from the Korean Cohort Study on COVID-19"},{"title3":"Clinical features and treatment of COVID-19 patients in northeast Chongqing"},{"title3":"Host susceptibility to severe COVID-19 and establishment of a host risk score: Findings of 487 cases outside Wuhan"},{"title3":"Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study"},{"title3":"Clinical characteristics of Covid-19 in New York City"},{"title3":"Prediction for progression risk in patients with COVID-19 pneumonia: The CALL Score"},{"title3":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan"},{"title3":"Risk factors for primary middle east respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014"},{"title3":"U.S. Department of Health and Human Services Center of Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion Office on Smoking and Health. Smoking Cessation. A report of the surgeon general. Atlanta, GA: 2020 [consultado 1 May 2020]. Disponible en: https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf"},{"title3":"Tobacco and waterpipe use increases the risk of suffering from COVID-19. World Health Organization (WHO) 2020 [consultado 1 May 2020]. Disponible en: http://www.emro.who.int/tfi/know-the-truth/tobacco-and-waterpipe-users-are-at-increased-risk-of-covid-19-infection.html"},{"title3":"Smoking Upregulates angiotensin-converting enzyme-2 receptor: A potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19)"},{"title3":"Naming the coronavirus disease (COVID-19) and the virus that causes it. World Health Organization (WHO) [consultado 1 Mayo 2020]. Disponible en: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it"}]},{"title2":"Tobacco and the lung cancer epidemic in China","References":[]},{"title2":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019:United States, February 12-March 28, 2020","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19):United States, February 12-March 16, 2020."},{"title3":"Heart disease and stroke statistics:2020 update: a report from the American Heart Association."},{"title3":"Urban-rural county and state differences in chronic obstructive pulmonary disease:United States, 2015."}]},{"title2":"Smoking may increase the risk of influenza hospitalization and reduce influenza vaccine effectiveness in the elderly","References":[]},{"title2":"Illustrating bias due to conditioning on a collider","References":[]},{"title2":"Nicotine and the renin-angiotensin system","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (Covid-19) outbreak in China: summary of a report of 72314 cases from the chinese Center for Disease Control and prevention"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ECA-2) converts angiotensin i to angiotensin 1-9"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"The site of angiotensin production"},{"title3":"Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists and calcium channel blocking agents: a review of potential benefits and possible adverse reactions"},{"title3":"Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area"},{"title3":"The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review"},{"title3":"Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?"},{"title3":"Nicotine and the renin-angiotensin system"},{"title3":"Mortality in relation to smoking: 50 years' observations on male British doctors"},{"title3":"Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis"},{"title3":"Smoking is associated with COVID-19 progression: a meta-analysis"},{"title3":"Risk factors for primary middle east respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014"},{"title3":"Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel Coronavirus SARS-CoV-2 (Cvid-19)"},{"title3":"ACE-2 expression in the small airway epithelia of smokers and COPD Patients: implications for COVID-19"},{"title3":"COVID-19 and smoking. Is nicotine the hidden link?"},{"title3":"Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population?"},{"title3":"Effects of methyllycaconitine (MLA), an alpha 7 nicotinic receptor antagonist, on nicotine- and cocaine-induced potentiation of brain stimulation reward"},{"title3":"Dimerization of alpha-conotoxins as a strategy to enhance the inhibition of the human alpha 7 and alpha 9, alpha 10 nicotinic acetylcholine receptors"}]},{"title2":"ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement"},{"title3":"STAR: ultrafast universal RNA-seq aligner"},{"title3":"voom: precision weights unlock linear model analysis tools for RNA-seq read counts"},{"title3":"Widespread sexual dimorphism in the transcriptome of human airway epithelium in response to smoking"},{"title3":"Threshold of biologic responses of the small airway epithelium to low levels of tobacco smoke"},{"title3":"A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment"},{"title3":"Hedgehog signaling in the airway epithelium of patients with chronic obstructive pulmonary disease"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Alternative roles of STAT3 and MAPK signaling pathways in the MMPs activation and progression of lung injury induced by cigarette smoke exposure in ACE2 knockout mice"},{"title3":"Role of angiotensin-converting enzyme (ACE) and ACE2 in a rat model of smoke inhalation induced acute respiratory distress syndrome"}]},{"title2":"Tobacco smoking increases the lung gene expression of ACE2, the receptor of SARS-CoV-2","References":[{"title3":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein"},{"title3":"The Cancer Genome Atlas Pan-Cancer Analysis Project"},{"title3":"The transcriptional landscape and mutational profile of lung adenocarcinoma"},{"title3":"Cigarette smoking induces changes in airway epithelial expression of genes associated with monogenic lung disorders"},{"title3":"Threshold of biologic responses of the small airway epithelium to low levels of tobacco smoke"},{"title3":"Down-regulation of the notch pathway in human airway epithelium in association with smoking and chronic obstructive pulmonary disease"},{"title3":"Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression"},{"title3":"A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment"},{"title3":"Molecular signature of smoking in human lung tissues"},{"title3":"Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution"},{"title3":"SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells"}]},{"title2":"Accounting for missing data in statistical analyses: multiple imputation is not always the answer","References":[]},{"title2":"Self-sampling for community respiratory illness: a new tool for national virological surveillance","References":[]}]},{"title1":"Characteristics and outcomes of COVID-19 patients in New York Citys public hospital system","References":[{"title2":"New York City Department of Health and Mental Hygiene. COVID-19: Data. https://www1.nyc.gov/site/doh/COVID/COVID-19-data.page. Accessed April 29, 2020.","References":[]},{"title2":"Clinical Characteristics of COVID-19 in New York City [published online April 17, 2020].","References":[{"title3":"COVID-19 Map"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Extrapulmonary manifestations of COVID-19"},{"title3":"Aki in hospitalized patients with and without COVID-19: a comparison study"},{"title3":"Aki in hospitalized patients with COVID-19"},{"title3":"Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection"},{"title3":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19"},{"title3":"Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction"},{"title3":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19"},{"title3":"Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2"},{"title3":"Thrombosis in hospitalized patients with COVID-19 in a new York City health system"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy"},{"title3":"States reporting cases of COVID-19 to CDC"},{"title3":"Defining the Epidemiology of Covid-19 - Studies Needed"},{"title3":"R: a language and environment for statistical computing. R found STAT comput Vienna, Austria; R foundation for statistical computing"},{"title3":"Epidemiology of Covid-19 in a long-term care facility in King County, Washington"},{"title3":"SARS-CoV-2 infection among travelers returning from Wuhan, China"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Estimates of the severity of coronavirus disease 2019: a model-based analysis"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Covid-19 in critically Ill patients in the seattle region - case series"},{"title3":"Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]"},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state"},{"title3":"Lactate dehydrogenase, a risk factor of severe COVID-19 patients"},{"title3":"Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis"},{"title3":"Clinical characteristics of Covid-19 in New York City"},{"title3":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application"}]},{"title2":"Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City.","References":[]},{"title2":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","References":[]},{"title2":"Clinical Characteristics of Hospitalized COVID-19 Patients in New York City","References":[]},{"title2":"Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area [published online April 22, 2020]","References":[]},{"title2":"Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes.","References":[]},{"title2":"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. [published online March 13, 2020]","References":[]},{"title2":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","References":[]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission [published online April 9, 2020]","References":[]},{"title2":"Gastrointestinal Symptoms and COVID-19: Case-Control Study from the United States [published online April 12, 2020]","References":[]},{"title2":"Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019:United States, February 12-March 28, 2020","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19):United States, February 12-March 16, 2020."},{"title3":"Heart disease and stroke statistics:2020 update: a report from the American Heart Association."},{"title3":"Urban-rural county and state differences in chronic obstructive pulmonary disease:United States, 2015."}]},{"title2":"Asthma Is Absent Among Top COVID-19 Risk Factors, Early Data Shows","References":[]},{"title2":"Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? [published online April 3, 2020]","References":[{"title3":"Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017"},{"title3":"Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019"},{"title3":"Chronic lower respiratory tract diseases"},{"title3":"Molecular choreography of acute exercise"},{"title3":"Blood factors transfer beneficial effects of exercise on neurogenesis and cognition to the aged brain"},{"title3":"Preventing or reversing immunosenescence: can exercise be an immunotherapy?"},{"title3":"Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases"},{"title3":"American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation"},{"title3":"Personalized exercise training in chronic lung diseases"},{"title3":"An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation"},{"title3":"An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease"},{"title3":"British Thoracic Society guideline on pulmonary rehabilitation in adults: accredited by NICE"},{"title3":"Pulmonary Rehabilitation: joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines"},{"title3":"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019"},{"title3":"Effects of home-based lower limb resistance training on muscle strength and functional status in stable Chronic obstructive pulmonary disease patients"},{"title3":"Effects of upper limb resistance exercise on aerobic capacity, muscle strength, and quality of life in COPD patients: a randomized controlled trial"},{"title3":"Arm strength training improves activities of daily living and occupational performance in patients with COPD"},{"title3":"Effects of Combined Resistance and Endurance Training Versus Resistance Training Alone on Strength, Exercise Capacity, and Quality of Life in Patients With COPD"},{"title3":"Low-load/high-repetition elastic band resistance training in patients with COPD: a randomized, controlled, multicenter trial"},{"title3":"Effects of Water-Based Aerobic Interval Training in Patients With COPD: a RANDOMIZED CONTROLLED TRIAL"},{"title3":"Pulmonary Rehabilitation in COPD: effect of 2 Aerobic Exercise Intensities on Subject-Centered Outcomes:A Randomized Controlled Trial"},{"title3":"Clinical benefits of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease"},{"title3":"Improving physical activity in patients with COPD with urban walking circuits"},{"title3":"COPD disease severity and innate immune response to pathogen-associated molecular patterns"},{"title3":"Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort"},{"title3":"Aerobic Exercise Alleviates Inflammation, Oxidative Stress, and Apoptosis in Mice with Chronic Obstructive Pulmonary Disease"},{"title3":"Systemic Inflammation, Vascular Function, and Endothelial Progenitor Cells after an Exercise Training Intervention in COPD"},{"title3":"Effect of an Exercise Program on Lymphocyte Proliferative Responses of COPD Patients"},{"title3":"Exercise alleviates depression related systemic inflammation in chronic obstructive pulmonary disease patients"},{"title3":"Aerobic Exercise Reduces Asthma Phenotype by Modulation of the Leukotriene Pathway"},{"title3":"Global Initiative for Asthma Strategy 2021: executive Summary and Rationale for Key Changes"},{"title3":"Asthma and Aerobic Exercise: a Review of the Empirical Literature"},{"title3":"Physical training for asthma"},{"title3":"Exploring and explaining low participation in physical activity among children and young people with asthma: a review"},{"title3":"Effect of an outpatient pulmonary rehabilitation program on exercise tolerance and asthma control in obese asthma patients"},{"title3":"Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma"},{"title3":"12-Week Inspiratory Muscle Training Improves Respiratory Muscle Strength in Adult Patients with Stable Asthma: a Randomized Controlled Trial"},{"title3":"Effect of a combined exercise program on physical fitness, lung function, and quality of life in patients with controlled asthma and exercise symptoms: a randomized controlled trial"},{"title3":"Exercise improves physical activity and comorbidities in obese adults with asthma"},{"title3":"Low volume high intensity interval training leads to improved asthma control in adults"},{"title3":"Effect of high-intensity interval training in adolescents with asthma: the eXercise for Asthma with Commando Joe's  (X4ACJ) trial"},{"title3":"Effects of Aerobic Training Versus Breathing Exercises on Asthma Control: a Randomized Trial"},{"title3":"Exercise training as an adjunctive therapy to montelukast in children with mild asthma: a randomized controlled trial"},{"title3":"Regular exercise improves asthma control in adults: a randomized controlled trial"},{"title3":"Laps or lengths? The effects of different exercise programs on asthma control in children"},{"title3":"Effects of exercise training on airway closure in asthmatics"},{"title3":"Evaluating pulmonary function, aerobic capacity, and pediatric quality of life following a 10-week aerobic exercise training in school-aged asthmatics: a randomized controlled trial"},{"title3":"Swimming and persons with mild persistant asthma"},{"title3":"The effects of a swimming intervention for children with asthma"},{"title3":"Feasibility of exercising adults with asthma: a randomized pilot study"},{"title3":"Effects of an aerobic physical training program on psychosocial characteristics, quality-of-life, symptoms and exhaled nitric oxide in individuals with moderate or severe persistent asthma"},{"title3":"Improvements in symptoms and quality of life following exercise training in older adults with moderate/severe persistent asthma"},{"title3":"Aerobic training decreases bronchial hyperresponsiveness and systemic inflammation in patients with moderate or severe asthma: a randomised controlled trial"},{"title3":"Effects of aerobic training on airway inflammation in asthmatic patients"},{"title3":"Effects of swimming on spirometric parameters and bronchial hyperresponsiveness in children and adolescents with moderate persistent atopic asthma"},{"title3":"Training of aerobic and anaerobic fitness in children with asthma"},{"title3":"Effects of aerobic training on psychosocial morbidity and symptoms in patients with asthma: a randomized clinical trial"},{"title3":"Effect of physical training on health-related quality of life in patients with moderate and severe asthma"},{"title3":"Effects of Exercise and Diet in Nonobese Asthma Patients:A Randomized Controlled Trial"},{"title3":"Effects of physical exercise training on nocturnal symptoms in asthma: systematic review"},{"title3":"Weight loss interventions for chronic asthma"},{"title3":"Evidence for mast cell activation during exercise-induced bronchoconstriction"},{"title3":"Endurance exercise diverts the balance between Th17 cells and regulatory T cells"},{"title3":"Physical activity and asthma: a systematic review and meta-analysis"},{"title3":"Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults"},{"title3":"Aerobic Exercise Decreases Lung Inflammation by IgE Decrement in an OVA Mice Model"},{"title3":"Winter Exercise Reduces Allergic Airway Inflammation: a Randomized Controlled Study"},{"title3":"Physical Training Reduces Chronic Airway Inflammation and Mediators of Remodeling in Asthma"},{"title3":"Bronchiectasis - A Clinical Review"},{"title3":"Determinants of Peripheral Muscle Strength and Activity in Daily Life in People With Bronchiectasis"},{"title3":"European Respiratory Society guidelines for the management of adult bronchiectasis"},{"title3":"Self-management for bronchiectasis"},{"title3":"Exercise Capacity and Physical Activity in Non-Cystic Fibrosis Bronchiectasis after a Pulmonary Rehabilitation Home-Based Programme: a Randomised Controlled Trial"},{"title3":"Home-based pulmonary rehabilitation in people with bronchiectasis: a randomised controlled trial"},{"title3":"Pulmonary rehabilitation in patients with bronchiectasis: pulmonary function, arterial blood gases, and the 6-minute walk test"},{"title3":"The Effect of Pulmonary Rehabilitation on the Physical Activity Level and General Clinical Status of Patients with Bronchiectasis"},{"title3":"Effects of Pulmonary Rehabilitation in Patients with Non-Cystic Fibrosis Bronchiectasis: a Retrospective Analysis of Clinical and Functional Predictors of Efficacy"},{"title3":"Effects of Pulmonary Rehabilitation on Systemic Inflammation and Exercise Capacity in Bronchiectasis: a Randomized Controlled Trial"},{"title3":"Efficacy of pulmonary rehabilitation on patients with non-cystic bronchiectasis according to disease severity"},{"title3":"Pulmonary rehabilitation in bronchiectasis: a propensity-matched study"},{"title3":"Effects of exercise on secretion transport, inflammation, and quality of life in patients with noncystic fibrosis bronchiectasis: protocol for a randomized controlled trial"},{"title3":"Autonomic nervous system adaptations to short-term exercise training"},{"title3":"Effect of airway Pseudomonas aeruginosa isolation and infection on steady-state bronchiectasis in Guangzhou, China"},{"title3":"Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo"},{"title3":"Mucus hypersecretion in bronchiectasis. The role of neutrophil proteases"},{"title3":"Lung Defense through IL-8 Carries a Cost of Chronic Lung Remodeling and Impaired Function"},{"title3":"Anti-Inflammatory Effects of Exercise on Metabolic Syndrome Patients: a Systematic Review and Meta-Analysis"},{"title3":"Aerobic Exercise Attenuates Acute Lung Injury Through NET Inhibition"},{"title3":"NADPH oxidase: a target for the modulation of the excessive oxidase damage induced by overtraining in rat neutrophils"},{"title3":"Respiratory Impairment, Limited Activity, and Pulmonary Rehabilitation in Patients with Interstitial Lung Disease"},{"title3":"Diagnosis of Interstitial Lung Diseases"},{"title3":"Quality of life and health status in interstitial lung diseases"},{"title3":"Impacto de la rehabilitacion pulmonar en pacientes con enfermedad pulmonar restrictiva"},{"title3":"Results of an 8-week, Outpatient Pulmonary Rehabilitation Program on Patients With and Without Chronic Obstructive Pulmonary Disease"},{"title3":"Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease"},{"title3":"Changes in fatigability following intense aerobic exercise training in patients with interstitial lung disease"},{"title3":"Pulmonary rehabilitation for interstitial lung disease"},{"title3":"Short-Term Effects of Comprehensive Pulmonary Rehabilitation and its Maintenance in Patients with Idiopathic Pulmonary Fibrosis: a Randomized Controlled Trial"},{"title3":"Pulmonary Rehabilitation in patients with Interstitial Lung Disease: the effects of a 12-week programme"},{"title3":"Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: a randomised controlled trial"},{"title3":"Efficacy of a Structured Exercise Program for Improving Functional Capacity and Quality of Life in Patients With Stage 3 and 4 Sarcoidosis: a RANDOMIZED CONTROLLED TRIAL"},{"title3":"The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial"},{"title3":"Effectiveness of pulmonary rehabilitation in patients with interstitial lung disease of different etiology: a multicenter prospective study"},{"title3":"Effects of different exercise training programs on the functional performance in fibrosing interstitial lung diseases: a randomized trial"},{"title3":"Pulmonary rehabilitation in patients with interstitial lung diseases: correlates of success"},{"title3":"Control of immunity by glucocorticoids in health and disease"},{"title3":"The compelling link between physical activity and the body's defense system"},{"title3":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries"},{"title3":"The 2015 World Health Organization Classification of Lung Tumors: impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification"},{"title3":"Lung Cancer 2020: epidemiology, Etiology, and Prevention"},{"title3":"Lung cancer: diagnosis and management"},{"title3":"Clinical application and mechanism of traditional Chinese medicine in treatment of lung cancer"},{"title3":"Radiotherapy treatment for lung cancer: current status and future directions"},{"title3":"Targeting ion channels for the treatment of lung cancer"},{"title3":"Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines"},{"title3":"Relationship between pulmonary function and lung cancer surgical outcome"},{"title3":"Pre-operative pulmonary rehabilitation and surgery for lung cancer"},{"title3":"The effect of incentive spirometry and inspiratory muscle training on pulmonary function after lung resection"},{"title3":"Prehabilitation in thoracic surgery"},{"title3":"The effect of radical treatment and rehabilitation on muscle mass and strength: a randomized trial in stages I-III lung cancer patients"},{"title3":"A comparison of the effects of medical Qigong and standard exercise therapy on symptoms and quality of life in patients with advanced cancer"},{"title3":"Randomised controlled trial on the effectiveness of home-based walking exercise on anxiety, depression and cancer-related symptoms in patients with lung cancer"},{"title3":"The effect of a 12-week home-based walking program on reducing fatigue in women with breast cancer undergoing chemotherapy: a randomized controlled study"},{"title3":"Preoperative pulmonary rehabilitation versus chest physical therapy in patients undergoing lung cancer resection: a pilot randomized controlled trial"},{"title3":"The effects of preoperative short-term intense physical therapy in lung cancer patients: a randomized controlled trial"},{"title3":"Short and long-term effects of supervised versus unsupervised exercise training on health-related quality of life and functional outcomes following lung cancer surgery - a randomized controlled trial"},{"title3":"Strength and endurance training in the treatment of lung cancer patients in stages IIIA/IIIB/IV"},{"title3":"Pulmonary rehabilitation in advanced lung cancer patients during chemotherapy"},{"title3":"Home-Based Preoperative Exercise Training for Lung Cancer Patients Undergoing Surgery: a Feasibility Trial"},{"title3":"Effects of a 12-Week Multimodal Exercise Intervention Among Older Patients with Advanced Cancer: results from a Randomized Controlled Trial"},{"title3":"Effects and tolerability of exercise therapy modality on cardiorespiratory fitness in lung cancer: a randomized controlled trial"},{"title3":"Combined aerobic exercise and high-intensity respiratory muscle training in patients surgically treated for non-small cell lung cancer: a pilot randomized clinical trial"},{"title3":"Exercise training for people following curative intent treatment for non-small cell lung cancer: a randomized controlled trial"},{"title3":"The Impact of a Multidimensional Exercise Intervention on Physical and Functional Capacity, Anxiety, and Depression in Patients With Advanced-Stage Lung Cancer Undergoing Chemotherapy"},{"title3":"An exercise prescription for patients with lung cancer improves the quality of life, depression, and anxiety"},{"title3":"Preoperative high-intensity interval training is effective and safe in deconditioned patients with lung cancer: a randomized clinical trial"},{"title3":"A review of cancer immunotherapy toxicity"},{"title3":"Alterations in the innate immune system due to exhausting exercise in intensively trained rats"},{"title3":"Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution"},{"title3":"Effects of exercise on immune function in patients with cancer: a systematic review"},{"title3":"NK cells to cure cancer"},{"title3":"Effect of Tai Chi on mononuclear cell functions in patients with non-small cell lung cancer"},{"title3":"Regular tai chi exercise decreases the percentage of type 2 cytokine-producing cells in postsurgical non-small cell lung cancer survivors"}]},{"title2":"NYC DOHMH. Age-adjusted rates of lab confirmed COVID-19. 2020 April 16. https://www1.nyc.gov/assets/doh/downloads/pdf/imm/COVID-19-deaths-race-ethnicity-04162020-1.pdf. Accessed April 20, 2020.","References":[]},{"title2":"NYC DOHMH. Age-adjusted rates of lab confirmed COVID-19. May 13, 2020. https://www1.nyc.gov/assets/doh/downloads/pdf/imm/covid-19-deaths-race-ethnicity-05142020-1.pdf. Accessed May 15, 2020.","References":[]},{"title2":"U.S. Census Bureau. Quick Facts: New York City, New York:Population Estimates, July 1, 2019. https://www.census.gov/quickfacts/newyorkcitynewyork. Accessed May 18, 2020.","References":[]},{"title2":"NYC DOHMH. NYC Health Data: EpiQuery. Community Health Survey 2017, Disease and Conditions. https://a816-health.nyc.gov/hdi/epiquery/visualizations?PageType = ts&amp;PopulationSource = CHS&amp;Topic = 1&amp;Subtopic = 24. Accessed April 20, 2020.","References":[]},{"title2":"COVID-19 exacerbating inequalities in the US","References":[]},{"title2":"U.S. Bureau of Labor Statistics. Economic News Release: Table 1. Workers who could work at home, did work at home, and were paid for work at home, by selected characteristics, averages for the period 2017-2018. September 24, 2020. https://www.bls.gov/news.release/flex2.t01.htm. Accessed April 20, 2020.","References":[]},{"title2":"U.S. Census Bureau. Quick Facts: New York City, New York:Population Estimates, July 1, 2019. https://www.census.gov/quickfacts/newyorkcitynewyork. Accessed April 20, 2020.","References":[]},{"title2":"New York City Health + Hospitals (NYC H+H). Mayor De Blasio and NYC Health + Hospitals Expand Appointment-Only COVID-19 Testing Capacity. New York City Health + Hospitals Press Release. March 19, 2020. https://www.nychealthandhospitals.org/pressrelease/mayor-de-blasio-and-nyc-health-hospitals-expand-appointment-only-COVID-19-testing. Accessed April 20, 2020.","References":[]},{"title2":"New York City Department of Health and Mental Hygiene (NYC DOHMH). 2020 Advisory #8: COVID-19 Update for New York City. March 20, 2020. https://www1.nyc.gov/assets/doh/downloads/pdf/han/advisory/2020/COVID-19-03202020.pdf. Accessed April 20, 2020.","References":[]},{"title2":"NYC H+H. New Coronavirus Testing Guidelines. https://www.nychealthandhospitals.org/coronavirus-testing-guidelines/?notification. Accessed April 20, 2020.","References":[]}]}]}